methamphetamine has been researched along with Psychoses, Drug in 258 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 44 (17.05) | 18.7374 |
1990's | 42 (16.28) | 18.2507 |
2000's | 71 (27.52) | 29.6817 |
2010's | 89 (34.50) | 24.3611 |
2020's | 12 (4.65) | 2.80 |
Authors | Studies |
---|---|
Babina, A; Sokolova, I; Vysotskyi, M | 1 |
Chen, T; Guan, FL; Han, W; Zhang, JB; Zhao, LR; Zhu, L | 1 |
Arunogiri, S; Berk, M; Castle, D; Clare, PJ; Kelly, PJ; Lubman, DI; Manning, V; McKetin, R; Turner, A | 1 |
Bach, PJ; Elefante, RJO; Nolan, S | 1 |
Chiang, M; Du, J; Fan, X; Harrington, A; Lombardi, D; Makrum, U; Shukair, N; Sitthichai, R; Zhao, M | 1 |
Chen, C; Hsu, FC; Huang, MC; Li, CW | 1 |
Liu, T; London, ED; Yang, C; Yang, M | 1 |
Alikhani, M; Brand, S; Farnia, V; Farshchian, F; Farshchian, N; Sadeghi Bahmani, D | 1 |
Ahmadkhaniha, HR; Bozorgnia, AR; Hadizadeh, H; Salehi, M | 1 |
Chan, G; Dawe, S; Hides, L; Kavanagh, DJ; McKetin, R; Saunders, JB; Teesson, M; Young, RM | 1 |
Piel, JL; Reisner, AD | 1 |
Burns, R; Calabria, B; Castle, D; McKetin, R; Voce, A | 4 |
Deng, H; Hu, W; Jia, X; Jiang, W; Kong, Z; Lai, W; Liu, T; Ren, P; Xie, C; Yang, M; Zhang, B; Zhao, M; Zhou, H | 1 |
Boden, JM; Foulds, JA; McKetin, R; Newton-Howes, G | 1 |
Bothe, L; Braunwarth, WD; Hamdorf, W; Härtel-Petri, R; Havemann-Reinecke, U; Jeschke, P; Krampe-Scheidler, A; Looser, W; Mühlig, S; Schaefer, C; Schäfer, I; Scherbaum, N | 1 |
Dalton, CF; Fachim, HA; Nudmamud-Thanoi, S; Reynolds, GP; Thanoi, S; Veerasakul, S; Watiktinkorn, P | 1 |
Arunogiri, S; Foulds, JA; Lubman, DI; McKetin, R | 1 |
Iamjan, SA; Nudmamud-Thanoi, S; Reynolds, GP; Thanoi, S; Watiktinkorn, P | 2 |
McKetin, R | 1 |
Baldwin, DS; Howells, FM; Hsieh, JH; Stein, DJ; Temmingh, HS; van Dijen, AV | 1 |
Baig, AM | 1 |
Jones, R; Usher, K; Woods, C | 1 |
Dawe, S; Hides, L; Kavanagh, DJ; McKetin, R; Saunders, JB | 1 |
Bao, YP; Blow, FC; Degenhardt, L; Ilgen, M; Lappin, J; Li, SX; Li, XD; Lu, L; Ma, J; Meng, SQ; Shi, J; Wang, TY; Wu, P | 1 |
Cordie, R; Johansen, A; Livermont, T; McFadden, LM | 1 |
Cai, WX; Hu, Q; Li, C; Liu, C; Tang, T; Zang, YY; Zhang, S | 1 |
Dugré, JR; Dumais, A; Lecomte, T; Potvin, S | 1 |
Hou, W; Tao, Y; Yu, L; Zeng, L; Zong, L | 1 |
Chang, L; Dong, C; Fujita, Y; Futamura, T; Hashimoto, K; Ohgi, Y; Pu, Y; Qu, Y; Ren, Q; Tian, Z; Zhang, K | 1 |
Dong, H; Hao, W; Liu, L; Liu, M; Shen, Y; Yang, C | 1 |
Lee, A; McInnis, P | 1 |
Lappin, JM; Sara, GE | 1 |
Dada, S; de Clercq, C; Kader, R; Lewis, I; Parker, JS; Parry, CD; Plüddemann, A; Temmingh, H; van Heerden, S | 1 |
Das, S; Guan, NC; Habil, MH; Midin, M; Nik Jaafar, NR; Rashid, R; Said, MA; Siddiq, A; Sidi, H; Sulaiman, AH | 1 |
Chen, YW; Kao, HY; Lai, WS; Min, MY | 1 |
Dwyer, R; Moore, D | 1 |
Hatim, A; Mohamed, Z; Reynolds, GP; Sim, MS | 1 |
Blake, B; Cloutier, RL; Fu, RR; Hendrickson, RG | 1 |
Aleksic, B; Aoyama-Uehara, K; Hashimoto, R; Ikeda, M; Iwata, N; Iyo, M; Kawamura, Y; Kondo, N; Miyagawa, T; Naruse, N; Nishida, N; Okahisa, Y; Ozaki, N; Sasaki, T; Sora, I; Takeda, M; Tokunaga, K; Ujike, H; Won, M | 1 |
Rusyniak, DE | 1 |
Kobayashi, O; Matsumoto, T; Tanibuchi, Y; Wada, K | 1 |
Chanasong, R; Nudmamud-Thanoi, S; Reynolds, GP; Thanoi, S; Watiktinkorn, P | 1 |
Carter, C; Fassbender, C; Iosif, AM; Leamon, MH; Salo, R; Ursu, S | 1 |
Baker, AL; Butterworth, P; Dawe, S; Lubman, DI; McKetin, R; Najman, JM | 1 |
Gelernter, J; Kalayasiri, R; Malison, RT; Mutirangura, A; Verachai, V | 1 |
Chawanakrasaesin, K; Kaewkungwal, J; Kalayasiri, R; Nilaban, S; Rukngan, W; Suwanmajo, S; Thanateerabunjong, R; Verachai, V | 1 |
Ding, Y; He, N; Lin, H; Yan, H; Zhou, L | 1 |
Glasner-Edwards, S; Mooney, LJ | 1 |
Fassbender, C; Lesh, TA; Salo, R; Ursu, S | 1 |
Ishii-Takahashi, A; Kasai, K; Kawasaki, S; Kinoshita, A; Koike, S; Nakakita, M; Nishimura, Y; Ohtani, T; Okada, N; Okazaki, Y; Sakakibara, E; Satomura, Y; Takahashi, K; Takizawa, R | 1 |
Bramness, JG; Medhus, SE; Rognli, EB | 1 |
Dawe, S; Hides, L; Kavanagh, DJ; McKetin, R; Saunders, JB; Teesson, M; Young, RM | 1 |
Atkinson, JH; Bousman, CA; Burns, R; Everall, IP; Grant, I; McKetin, R; Morgan, EE; Woods, SP | 1 |
Harro, J | 1 |
Naruse, N | 1 |
Halberstadt, AL; Manning, EE; van den Buuse, M | 1 |
Burns, RA; Dawe, S; Hides, L; Kavanagh, DJ; McD Young, R; McKetin, R; Saunders, JB; Teesson, M; Voce, A | 1 |
Ahmadi, R; Hamidi, A; Khalkhali, M; Zarrabi, H; Zavarmousavi, M | 1 |
Fouche, JP; Lederer, K; Meintjes, EM; Stein, DJ; Uhlmann, A; Wilson, D | 1 |
Ali, R; Baker, AL; Dawe, S; Gardner, J; Leach, LS; Lubman, DI; McKetin, R; Voce, A | 1 |
Aleksic, A; Barr, AM; Gicas, K; Honer, WG; Jones, AA; Leonova, O; MacEwan, GW; Panenka, WJ; Procyshyn, RM; Thornton, AE; Vila-Rodriguez, F; Willi, TS | 1 |
Breen, MS; Glatt, SJ; Illing, N; Metsalpu, A; Mitt, M; Nday, CM; Stein, DJ; Uhlmann, A | 1 |
Bajoghli, H; Brand, S; Farnia, V; Golshani, S; Holsboer-Trachsler, E; Hookari, S; Juibari, TA; Shakeri, J; Tatari, F | 1 |
Burns, L; Chalmers, J; Dobbins, T; Farrell, M; Kaye, S; Lappin, JM; Roxburgh, A; Sara, G | 1 |
Javadian, S; Shabani, A; Shariat, SV | 1 |
Howells, FM; Shelly, J; Sibeko, G; Sinclair, H; Stein, DJ; Temmingh, H; Uhlmann, A; Wilson, D | 1 |
Amini, H; Hajebi, A; Kashani, L; Sharifi, V | 1 |
Pieterse, D; Temmingh, H; Vogel, W | 1 |
Alexander, PD; Barr, AM; Boyeva, V; Gicas, KM; Honer, WG; Jones, AA; Kim, CN; Lang, DJ; Panenka, WJ; Procyshyn, RM; Smith, GN; Thornton, AE; Vila-Rodriguez, F; Willi, TS; William MacEwan, G | 1 |
Baker, AL; Dawe, S; Lubman, DI; McKetin, R; Voce, A | 1 |
Antonipillai, J; Apostolopoulos, V; Nurgali, K; Prakash, MD; Stojanovska, L; Tangalakis, K | 1 |
Ago, Y; Arikawa, S; Matsuda, T; Nakamura, S; Yata, M | 1 |
Bello, I; Fujii, D; Jacobs, E; Schiffman, J | 1 |
Endo, K; Hirayasu, Y; Kobayashi, O; Matsumoto, T; Okudaira, K; Otsuki, M; Wada, K | 1 |
Harano, M; Hori, T; Inada, T; Iwata, N; Iyo, M; Kishimoto, M; Komiyama, T; Kotaka, T; Kuroda, S; Morita, Y; Okahisa, Y; Ozaki, N; Sekine, Y; Sora, I; Ujike, H; Yamada, M | 1 |
Anitha, A; Ezaki, N; Harano, M; Inada, T; Iwata, N; Iwata, Y; Iyo, M; Kawai, M; Komiyama, T; Mori, N; Nakamura, K; Sekine, Y; Sora, I; Suzuki, K; Takebayashi, K; Takei, N; Thanseem, I; Ujike, H; Yamada, M | 1 |
Aleksic, B; Harano, M; Hori, T; Ikeda, M; Inada, T; Iwata, N; Iyo, M; Kawashima, K; Kinoshita, Y; Kishi, T; Kitajima, T; Komiyama, T; Ohkouchi, T; Ozaki, N; Sekine, Y; Sora, I; Ujike, H; Yamada, M; Yamanouchi, Y | 1 |
Harano, M; Hori, T; Ikeda, M; Inada, T; Iwata, N; Iyo, M; Kawashima, K; Kinoshita, Y; Kishi, T; Kitajima, T; Komiyama, T; Ozaki, N; Sekine, Y; Sora, I; Ujike, H; Yamada, M; Yamanouchi, Y | 2 |
Davis, P; Dawe, S; Kavanagh, D; Lapworth, K; Saunders, J; Young, R | 1 |
Bousman, CA; Everall, IP; Glatt, SJ; Tsuang, MT | 1 |
Inada, T; Iwata, N; Iyo, M; Katsu, T; Kodama, M; Kuroda, S; Okahisa, Y; Ozaki, N; Sora, I; Takaki, M; Uchimura, N; Ujike, H; Yamada, M | 1 |
Tucker, P | 1 |
Bruijnzeel, AW; Cadet, JL; Gold, MS; Kobeissy, FH; Krasnova, IN; Merlo, LJ; Wang, KK | 1 |
Anitha, A; Harano, M; Inada, T; Iwata, N; Iwata, Y; Iyo, M; Komiyama, T; Mori, N; Nakamura, K; Ozaki, N; Sekine, Y; Sora, I; Suzuki, K; Takei, N; Ujike, H; Yamada, M | 1 |
Ikeda, M; Inada, T; Iwata, N; Iyo, M; Kawashima, K; Kinoshita, Y; Kishi, T; Kitajima, T; Okochi, T; Okumura, T; Ozaki, N; Sora, I; Tsunoka, T; Uchimura, N; Ujike, H; Yamada, M; Yamanouchi, Y | 2 |
Ikeda, M; Inada, T; Iwata, N; Iyo, M; Kawashima, K; Kinoshita, Y; Kishi, T; Kitajima, T; Okochi, T; Okumura, T; Ozaki, N; Sora, I; Tsunoka, T; Uchimura, N; Ujike, H; Yamada, M | 1 |
Inada, T; Iwata, N; Iyo, M; Kodama, M; Kotaka, T; Kuroda, S; Nakata, K; Okahisa, Y; Ozaki, N; Sora, I; Takaki, M; Uchimura, N; Ujike, H; Yamada, M | 1 |
Pienaar, W; Weich, L | 1 |
Huang, MC; Lin, HC; Lin, SK; Pan, CH | 1 |
Grelotti, DJ; Kanayama, G; Pope, HG | 1 |
Inada, T; Iwata, N; Iyo, M; Kawashima, K; Kinoshita, Y; Kishi, T; Kitajima, T; Naitoh, H; Okochi, T; Okumura, T; Ozaki, N; Sora, I; Tsunoka, T; Uchimura, N; Ujike, H; Yamada, M; Yamanouchi, Y | 1 |
Harada, K; Katsuoka, M; Kondo, Y; Matsuoka, N; Mihara, T; Ni, K; Shobo, M; Yamada, H; Yamamoto, N | 1 |
Nagai, T; Yamada, K | 1 |
Marshall, BD; Werb, D | 1 |
Fukuo, Y; Inada, T; Iwata, N; Iyo, M; Kawashima, K; Kishi, T; Kitajima, T; Naitoh, H; Okochi, T; Ozaki, N; Sora, I; Uchimura, N; Ujike, H; Yamada, M | 1 |
De La Garza, R; Hawkins, RY; Kalechstein, AD; Mahoney, JJ; Newton, TF | 1 |
Freissmuth, M; Montgomery, T; Sitte, HH; Steinkellner, T | 1 |
Ali, R; Arunpongpaisal, S; Kongsakon, R; Marsden, J; Srisurapanont, M; Wada, K | 1 |
Hashimoto, K; Iyo, M; Kanahara, N; Okamura, N; Sekine, Y; Tadokoro, S | 1 |
Bevins, RA; Carlo, G; Gendelman, HE; Grant, KM; LeVan, TD; Li, M; Stoltenberg, SF; Wells, SM | 1 |
Correll, CU; Fukuo, Y; Inada, T; Iwata, N; Iyo, M; Kishi, T; Kitajima, T; Okochi, T; Ozaki, N; Sora, I; Uchimura, N; Ujike, H; Yamada, M | 1 |
North, J | 1 |
Kasick, DP; Klisovic, E; McKnight, CA | 1 |
Halter, MJ; Levine, C; Wieland, DM | 1 |
Gill, JS; Guan, NC; Hussein, HM; Said, MA; Sulaiman, AH; Zainal, NZ | 1 |
Frazee, CC; Garg, U; Hair, LS; Hargraves, TL; Massucci, CJ; Pearson, JM; Pietak, BR | 1 |
Gestring, RE; Penders, TM; Vilensky, DA | 1 |
Bajaj, N; Mullen, D; Wylie, S | 1 |
Gururajan, A; Klug, M; Manning, EE; van den Buuse, M | 1 |
Chiles, C; Joksovic, P; Mellos, N; van Wattum, PJ | 1 |
Bramness, JG; Franck, J; Gundersen, ØH; Guterstam, J; Konstenius, M; Løberg, EM; Medhus, S; Rognli, EB; Tanum, L | 1 |
Ali, RL; Baker, AL; Dawe, S; Lubman, DI; McKetin, R | 1 |
Fasihpour, B; Molavi, S; Shariat, SV | 1 |
Ali, R; Farrell, M; Ling, W; Marsden, J | 1 |
Endo, K; Iseki, E; Kamijo, A; Kishimoto, H; Kosaka, K; Matsumoto, T; Miyakawa, T; Okudaira, K; Sakai, T; Yabana, T | 1 |
Harano, M; Inada, T; Iyo, M; Katsu, T; Komiyama, T; Nakata, K; Nomura, A; Ozaki, N; Sekine, Y; Sora, I; Ujike, H; Yamada, M | 1 |
Futatsubashi, M; Iyo, M; Minabe, Y; Mori, N; Nakamura, K; Okada, H; Ouchi, Y; Sekine, Y; Suzuki, K; Takei, N; Tsukada, H; Yoshikawa, E | 1 |
CARR, RB | 1 |
PROUT, CT | 1 |
Goto, K; Ikemoto, S; Kato, S; Nishijima, K; Yui, K | 1 |
Ali, R; Marsden, J; Monteiro, M; Srisurapanont, M; Sunga, A; Wada, K | 1 |
Ball, D; Chen, CK; Chiang, YL; Hsiao, CC; Lee, CH; Lin, SK; Loh, EW; Murray, RM; Ree, SC; Sham, PC | 1 |
Honda, M | 1 |
Chang, JG; Chen, SL; Hu, CJ; Leu, SJ; Lin, SK; Liu, HC; Liu, SK | 1 |
Sato, M; Ujike, H | 1 |
Iyo, M; Mori, N; Sekine, Y | 1 |
Goto, K; Ikemoto, S; Yui, K | 1 |
Abe, H; Harano, M; Iida, N; Inada, T; Ishibashi, M; Iyo, M; Komiyama, T; Maeda, H; Ozaki, N; Sekine, Y; Sora, I; Tanaka, T; Uchimura, N; Ujike, H; Yamada, M; Yanagimoto, K | 1 |
Harano, M; Hasegawa, J; Ide, S; Ikeda, K; Inada, T; Iyo, M; Kobayashi, H; Komiyama, T; Ozaki, N; Sekine, Y; Shen, HW; Sora, I; Ujike, H; Yamada, M | 1 |
Härtel-Petri, R; Rodler, R; Schmeisser, U; Steinmann, J; Wolfersdorf, M | 1 |
Harano, M; Hashimoto, K; Hashimoto, T; Inada, T; Iwata, N; Iyo, M; Komiyama, T; Matsuzawa, D; Ozaki, N; Sekine, Y; Shimizu, E; Sora, I; Ujike, H; Yamada, M | 1 |
Ozaki, S; Wada, K | 1 |
Bierman, B; Peck, JA; Reback, CJ; Rotheram-Fuller, E; Shoptaw, S | 1 |
Harano, M; Hashimoto, K; Inada, T; Iwata, N; Iyo, M; Koike, K; Koizumi, H; Komiyama, T; Matsuzawa, D; Ohgake, S; Okamura, N; Ozaki, N; Sekine, Y; Shimizu, E; Shirayama, Y; Sora, I; Ujike, H; Yamada, M | 1 |
Dore, G; Sweeting, M | 1 |
Ishii, S; Ito, T; Kaneko, Y; Kashiwa, A; Nishikawa, T; Umino, A | 1 |
Harano, M; Hata, H; Ide, S; Ikeda, K; Inada, T; Itokawa, M; Iwata, N; Iyo, M; Kobayashi, H; Komiyama, T; Naka, M; Numachi, Y; Ozaki, N; Sekine, Y; Sora, I; Ujike, H; Yamada, M | 1 |
Anitha, A; Ball, DM; Chen, CK; Harano, M; Inada, T; Iwata, N; Iwata, Y; Iyo, M; Kawai, M; Komiyama, T; Lin, SK; Loh, el-W; Minabe, Y; Mori, N; Nakamura, K; Ozaki, N; Sekine, Y; Sora, I; Suzuki, A; Suzuki, K; Takebayashi, K; Takei, N; Tsuchiya, K; Ujike, H; Yamada, K; Yamada, M; Yoshikawa, T | 1 |
Fujisaki, M; Hagiwara, H; Hashimoto, K; Iyo, M; Kojima, T; Miyatake, R; Shimizu, E; Watanabe, H | 1 |
Barr, AM; Honer, WG; Lang, DJ; Lecomte, T; MacEwan, GW; Panenka, WJ; Thornton, AE | 1 |
Hides, L; Lubman, DI; McKetin, R; McLaren, J | 1 |
Fukazawa, Y; Kiguchi, N; Kishioka, S; Maeda, T; Ozaki, M; Yamamoto, A | 1 |
Huff, C | 1 |
Fulde, GW; Wodak, A | 1 |
Daly, FF; Fatovich, DM; Gray, SD; McCoubrie, DL | 1 |
Degenhardt, L; McKetin, R; Roxburgh, A | 1 |
Harano, M; Hori, T; Inada, T; Iwata, N; Iyo, M; Kishimoto, M; Komiyama, T; Kotaka, T; Kuroda, S; Motohashi, Y; Okahisa, Y; Ozaki, N; Sekine, Y; Sora, I; Tanaka, Y; Ujike, H; Yamada, M | 1 |
Harano, M; Hori, T; Inada, T; Iwata, N; Iyo, M; Kishimoto, M; Komiyama, T; Kotaka, T; Kuroda, S; Morita, Y; Okahisa, Y; Ozaki, N; Sekine, Y; Sora, I; Tanaka, Y; Ujike, H; Yamada, M | 1 |
Harano, M; Hashimoto, K; Hata, A; Inada, T; Iwata, N; Iyo, M; Komiyama, T; Maeda, K; Mashimo, Y; Matsuzawa, D; Miyatake, R; Ozaki, N; Sawa, A; Sekine, Y; Shimizu, E; Shirayama, Y; Sora, I; Suzuki, Y; Ujike, H; Yamada, M | 1 |
Chen, CK; Chiang, SC; Chiang, YL; Hsiao, CC; Huang, MC; Lin, SK; Liu, HC; Ree, SC; Su, LW | 1 |
Carter, CS; Leamon, MH; Moore, CD; Natsuaki, Y; Nordahl, TE; Salo, R; Waters, C | 1 |
Inada, T; Oda, T; Yamamoto, N | 1 |
Chung, YK; Ha, HJ; Jang, J; Jung, MW; Kim, YB | 1 |
Hashimoto, K | 1 |
Ujike, H | 2 |
Kashiwabara, K; Otsuki, S; Sato, M | 1 |
Konuma, K | 1 |
Ikeda, T; Inotani, T; Takezaki, H; Yasuoka, T | 1 |
Yukitake, A | 1 |
Sato, M | 5 |
Akiyama, K; Chen, CC; Otsuki, S; Sato, M | 1 |
Bush, SC; Liebowitz, MR; McGrath, PJ | 1 |
Goto, K; Ikemoto, S; Ishiguro, T; Yui, K | 9 |
Iwanami, A; Kamijima, K; Kanamori, R; Kaneko, T; Suga, I | 1 |
Kunishima, C; Nabeshima, T; Shibuya, H; Toru, M; Yamada, K; Yoshikawa, T | 1 |
Iwanami, A; Kaneko, T; Nakatani, Y; Suga, I; Sugiyama, A | 1 |
Horita, N; Iwanami, A; Kaneko, T; Kato, N; Kuroki, N; Nakatani, Y; Sugiyama, A; Toda, S | 1 |
Iwanami, A; Kaneko, T; Kato, N; Nakatani, Y; Suga, I | 1 |
Fukuda, H; Fukui, S; Itoh, T; Iyo, M; Nishio, M; Suzuki, K; Tateno, Y; Yamasaki, T | 1 |
Nakayama, M | 1 |
Fuse, Y; Matsuoka, H; Numachi, Y; Sato, M; Yoshida, S | 1 |
Matsushima, E; Shimazono, Y | 1 |
Hashimoto, H; Kai, T; Kariyama, H; Katayama, M; Kawakita, Y; Koide, S; Nakamura, Y; Onishi, H; Yamagami, S | 1 |
Abekawa, T | 1 |
Kofoed, L; Misra, L | 1 |
Derlet, RW; Duncan, DR; Richards, JR | 1 |
Murray, JB | 1 |
Hara, T; Nakatani, Y | 1 |
Tretter, F | 1 |
Teraoka, A | 2 |
Iritani, S; Isono, H; Iwanami, A; Kamijima, K; Kuroki, N; Okajima, Y | 1 |
Buffenstein, A; Heaster, J; Ko, P | 1 |
Iyo, M; Matsunaga, T; Mori, N; Sekine, Y; Takei, N; Tsukamoto, T | 1 |
Goto, K; Ikemoto, S; Ishiguro, T; Kamata, Y; Yui, K | 2 |
Ito, K | 1 |
Jodo, E; Kayama, Y; Matsuki, T; Niwa, S; Suzuki, Y; Takeuchi, S | 1 |
Huang, YH; Sim, CB; Su, TW; Tsai, SJ | 1 |
Goto, K; Ikemoto, S; Ishiguro, T; Kamada, Y; Yui, K | 1 |
Ali, SF; Angrist, B; Bracha, SH; Duncan, GE; Goto, K; Ikemoto, S; Ishiguro, T; Lieberman, JA; Sheitman, BB; Yui, K | 1 |
Kofoed, L; Misra, LK; Oesterheld, JR; Richards, GA | 1 |
Bartel, RL; Goodhue, A; Smith, NB | 1 |
Matsumoto, T | 1 |
Futatsubashi, M; Iyo, M; Matsunaga, T; Mori, N; Okada, H; Ouchi, Y; Sekine, Y; Takei, N; Tsukada, H; Yoshikawa, E | 1 |
Goto, K; Ikemoto, S; Ishiguro, T; Nishijima, K; Yoshino, T; Yui, K | 1 |
Lee, YC; Sun, HJ; Wan, SR; Yeh, HS | 1 |
Fujii, D | 1 |
Cohen, S | 1 |
Siomopoulos, V | 1 |
Iyo, M | 1 |
Heffez, LB; Lee, CY; Mohammadi, H | 1 |
Machiyama, Y | 1 |
Hamamura, T; Numachi, Y; Sato, M | 1 |
Iwanami, A; Kato, N; Nakatani, Y | 1 |
Tomiyama, G | 1 |
Fukui, S; Wada, K | 1 |
Derlet, RW; Heischober, B | 1 |
Ando, H; Ando, K; Kojima, T; Matsushima, E; Nakajima, K; Shimazono, Y; Shiraishi, H | 1 |
Iwanami, A; Katoh, N; Nakatani, Y; Sakaguchi, M; Yamada, H; Yoshizawa, F | 1 |
Jackson, JG | 1 |
Fujimori, H; Nakatani, Y; Sakaguchi, M | 1 |
Akiyama, K; Hamamura, T; Onoue, T; Otsuki, S; Ujike, H | 1 |
Ichikawa, J | 1 |
Ichikawa, J; Inoue, T; Koyama, T; Matsubara, R; Nakayama, M | 1 |
Arikawa, K; Harajiri, S; Inanaga, K; Kojima, H; Miura, C | 1 |
Kuribara, H; Tadokoro, S | 1 |
Ando, K; Hironaka, N; Yanagita, T | 1 |
Ando, H; Ando, K; Iwama, H; Kojima, T; Matsushima, E; Moriya, H; Shimazono, Y; Takahashi, R | 1 |
Deshimaru, M; Miyakawa, T; Murayama, E; Sumiyoshi, S; Tatetsu, S | 2 |
Fog, R | 1 |
Bell, DS | 1 |
Ellinwood, EH; Grabowy, R; Sudilovsky, A | 1 |
Ellinwood, EH; Nelson, LM; Sudilovsky, A | 1 |
Ziolko, HU | 1 |
Beckett, AH; Rowland, M | 1 |
Cox, C; Smart, RG | 1 |
Cohen, S; Ellinwood, EH | 1 |
Munkvad, I; Randrup, A | 1 |
Ellinwood, EH | 1 |
Connell, PH; Gardner, R | 1 |
Heath, RG | 1 |
Ellinwood, EH; Nelson, L; Sudilovsky, A | 1 |
Friedhoff, AJ; Schweitzer, JW | 1 |
Fischer, CM; Smith, DE | 1 |
Kozuma, Y; Miyagawa, T; Takaki, M; Tatetsu, S | 1 |
Rose, AJ; Smith, DE | 1 |
Utena, H | 1 |
42 review(s) available for methamphetamine and Psychoses, Drug
Article | Year |
---|---|
Methamphetamine-associated psychosis: Clinical presentation, biological basis, and treatment options.
Topics: Antipsychotic Agents; Cognitive Behavioral Therapy; Electroacupuncture; Exercise Therapy; Humans; Inflammation; Methamphetamine; Neurotransmitter Agents; Oxidative Stress; Prefrontal Cortex; Psychoses, Substance-Induced; Schizophrenia | 2019 |
Structural, functional, and neurochemical neuroimaging of methamphetamine-associated psychosis: A systematic review.
Topics: Adult; Brain; Central Nervous System Stimulants; Cognition; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Methamphetamine; Middle Aged; Nerve Net; Neuroimaging; Psychoses, Substance-Induced | 2019 |
Evidence-Based Guidelines for the Pharmacologic Management of Methamphetamine Dependence, Relapse Prevention, Chronic Methamphetamine-Related, and Comorbid Psychiatric Disorders in Post-Acute Settings.
Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Benzodiazepines; Comorbidity; Evidence-Based Medicine; Humans; Mental Disorders; Methamphetamine; Practice Guidelines as Topic; Psychoses, Substance-Induced; Recurrence; Secondary Prevention | 2017 |
A systematic review of risk factors for methamphetamine-associated psychosis.
Topics: Amphetamine-Related Disorders; Central Nervous System Stimulants; Humans; Methamphetamine; Psychoses, Substance-Induced; Risk Factors | 2018 |
Methamphetamine psychosis: insights from the past.
Topics: Amphetamine; Humans; Methamphetamine; Paranoid Disorders; Psychoses, Substance-Induced | 2018 |
Electroencephalographic delta/alpha frequency activity differentiates psychotic disorders: a study of schizophrenia, bipolar disorder and methamphetamine-induced psychotic disorder.
Topics: Adult; Alpha Rhythm; Biomarkers; Bipolar Disorder; Case-Control Studies; Delta Rhythm; Female; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Schizophrenia; Young Adult | 2018 |
Rates and features of methamphetamine-related presentations to emergency departments: An integrative literature review.
Topics: Emergency Service, Hospital; Female; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Substance-Related Disorders | 2018 |
The prevalence of substance-induced psychotic disorder in methamphetamine misusers: A meta-analysis.
Topics: Amphetamine-Related Disorders; Humans; Methamphetamine; Prevalence; Psychoses, Substance-Induced | 2018 |
A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis
Topics: Amphetamine-Related Disorders; Humans; Methamphetamine; Psychoses, Substance-Induced | 2019 |
Psychostimulant use and the brain.
Topics: Amphetamine; Amphetamine-Related Disorders; Brain; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Cognitive Dysfunction; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Seizures; Stroke | 2019 |
Neurologic manifestations of chronic methamphetamine abuse.
Topics: Amphetamine-Related Disorders; Cognition Disorders; Dental Caries; Dyskinesia, Drug-Induced; Humans; Methamphetamine; Paresthesia; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Stereotyped Behavior | 2013 |
Methamphetamine psychosis: epidemiology and management.
Topics: Central Nervous System Stimulants; Humans; Methamphetamine; Psychoses, Substance-Induced | 2014 |
Neuropsychiatric Adverse Effects of Amphetamine and Methamphetamine.
Topics: Aggression; Amphetamine; Amphetamine-Related Disorders; Brain; Cognition Disorders; Humans; Mental Disorders; Methamphetamine; Psychoses, Substance-Induced | 2015 |
[Methamphetamine, cannabis].
Topics: Cannabis; Humans; Japan; Marijuana Abuse; Methamphetamine; Psychoses, Substance-Induced; Substance-Related Disorders | 2015 |
Methamphetamine: Effects on the brain, gut and immune system.
Topics: Animals; Brain; Central Nervous System Stimulants; Delusions; Depression; Gastrointestinal Tract; Humans; Immune System; Methamphetamine; Psychoses, Substance-Induced | 2017 |
[Involvement of prefrontal serotonergic neurons in methamphetamine-induced behavioral sensitization].
Topics: Animals; Central Nervous System Stimulants; Disease Models, Animal; Humans; Methamphetamine; Mice; Motor Activity; Neurons; Prefrontal Cortex; Psychoses, Substance-Induced; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT2; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Stimulation, Chemical; Substance-Related Disorders | 2008 |
Genetic association studies of methamphetamine use disorders: A systematic review and synthesis.
Topics: Amphetamine-Related Disorders; Genetic Association Studies; Humans; Methamphetamine; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced | 2009 |
Substance misuse and early psychosis.
Topics: Adolescent; Adult; Age of Onset; Alcohol Drinking; Amphetamine-Related Disorders; Cognition Disorders; Humans; Marijuana Abuse; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Substance-Related Disorders; Young Adult | 2009 |
Methamphetamine- and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates.
Topics: Animals; Brain Injuries; Cell Death; Central Nervous System Stimulants; Humans; Methamphetamine; Neurons; Proteomics; Psychoses, Substance-Induced | 2009 |
Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature.
Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Central Nervous System Stimulants; Electroconvulsive Therapy; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Treatment Outcome | 2010 |
[Molecular mechanism for methamphetamine-induced memory impairment].
Topics: Animals; Antipsychotic Agents; Central Nervous System Stimulants; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Humans; Memory Disorders; Methamphetamine; Mice; Mitogen-Activated Protein Kinase 3; Psychoses, Substance-Induced; Rats; Receptors, GABA; Substance-Related Disorders | 2010 |
Health outcomes associated with methamphetamine use among young people: a systematic review.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Child; Cross-Sectional Studies; Depressive Disorder; Drug Overdose; Female; Health Status; Humans; International Classification of Diseases; Male; Mental Disorders; Methamphetamine; Pregnancy; Psychoses, Substance-Induced; Review Literature as Topic; Sexually Transmitted Diseases; Stomatognathic Diseases; Suicide; Young Adult | 2010 |
The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.
Topics: Amphetamines; Animals; Dextroamphetamine; Humans; Methamphetamine; Mitochondria; Molecular Structure; N-Methyl-3,4-methylenedioxyamphetamine; Psychoses, Substance-Induced; Substance-Related Disorders; Time Factors | 2011 |
Methamphetamine-associated psychosis.
Topics: Animals; Central Nervous System Stimulants; Genetic Predisposition to Disease; Humans; Methamphetamine; Psychoses, Substance-Induced | 2012 |
Drugs of abuse and increased risk of psychosis development.
Topics: Age of Onset; Animals; Behavioral Symptoms; Brain; Cannabis; Dopamine; Dopamine Uptake Inhibitors; Functional Neuroimaging; Genetic Predisposition to Disease; Glutamic Acid; Humans; Illicit Drugs; Methamphetamine; Models, Animal; Psychoses, Substance-Induced; Risk Factors; Schizophrenia; Substance-Related Disorders | 2012 |
Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?
Topics: Amphetamine; Diagnosis, Differential; Disease Susceptibility; Humans; Methamphetamine; Models, Psychological; Psychoses, Substance-Induced; Risk Factors; Schizophrenia | 2012 |
Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis.
Topics: Adult; Amphetamine-Related Disorders; Animals; Humans; Japan; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induced | 2004 |
The need for speed: an update on methamphetamine addiction.
Topics: Amphetamine-Related Disorders; Animals; Brain; Central Nervous System Stimulants; Cognition Disorders; Cross-Sectional Studies; Disease Models, Animal; Humans; Methamphetamine; Neurotoxicity Syndromes; Psychoses, Substance-Induced | 2006 |
[Minocycline as a therapeutic drug for methamphetamine use disorders].
Topics: Animals; Anti-Bacterial Agents; Brain; Disease Models, Animal; Humans; Methamphetamine; Minocycline; N-Methyl-3,4-methylenedioxyamphetamine; Positron-Emission Tomography; Psychoses, Substance-Induced; Schizophrenia; Substance-Related Disorders | 2008 |
[Potential genetic predictors for individual vulnerability to substance dependence].
Topics: Carrier Proteins; Dysbindin; Dystrophin-Associated Proteins; Forecasting; Genetic Predisposition to Disease; Glutathione S-Transferase pi; Glutathione Transferase; Glycine Plasma Membrane Transport Proteins; Haplotypes; Humans; Methamphetamine; Odds Ratio; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Risk; Substance-Related Disorders | 2008 |
Behavioral and neuroimaging studies on schizophrenia in Japan.
Topics: Brain; Chronic Disease; Exploratory Behavior; Eye Movements; Fixation, Ocular; Humans; Incidence; Japan; Magnetic Resonance Imaging; Maze Learning; Methamphetamine; Play and Playthings; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1995 |
Psychophysiological aspects of amphetamine-methamphetamine abuse.
Topics: Amphetamine-Related Disorders; Amphetamines; Behavior, Addictive; Humans; Methamphetamine; Psychoses, Substance-Induced; Substance Withdrawal Syndrome | 1998 |
Disturbance of consciousness due to methamphetamine abuse. A study of 2 patients.
Topics: Central Nervous System Stimulants; Consciousness Disorders; Delirium; Delusions; Hallucinations; Humans; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induced; Substance Abuse, Intravenous; Substance-Related Disorders | 1998 |
Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization.
Topics: Animals; Brain Chemistry; Cocaine-Related Disorders; Hallucinogens; Humans; Methamphetamine; Phencyclidine; Predictive Value of Tests; Psychoses, Substance-Induced; Recurrence; Schizophrenia; Sensory Thresholds; Sympathomimetics | 1999 |
Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia.
Topics: Amphetamines; Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Humans; Japan; Methamphetamine; Psychoses, Substance-Induced; Research; Schizophrenia; Substance-Related Disorders | 2000 |
[Advanced findings on the molecular mechanisms for behavioral sensitization to psychostimulants].
Topics: Animals; Bacterial Proteins; Central Nervous System Stimulants; Cocaine; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Mice, Knockout; Nerve Tissue Proteins; Neuronal Plasticity; Neuropeptides; Proto-Oncogene Proteins c-fos; Psychoses, Substance-Induced; Receptor, Serotonin, 5-HT1B; Receptors, Dopamine D1; Receptors, Serotonin; Repressor Proteins; Substance-Related Disorders; Synaptophysin; Tissue Plasminogen Activator; Transcription Factors; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2001 |
[Basic and clinical studies on methampetamine-related psychosis].
Topics: Adult; Animals; Crime; Diagnosis, Differential; Dopamine; Forensic Psychiatry; Humans; Japan; Male; Methamphetamine; Middle Aged; Nerve Net; Psychoses, Substance-Induced; Schizophrenia; Substance-Related Disorders; Time Factors | 2002 |
Relapse of paranoid psychotic state in methamphetamine model of schizophrenia.
Topics: Animals; Cocaine; Cross-Sectional Studies; Dopamine; Female; Humans; Japan; Male; Methamphetamine; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology; Terminology as Topic | 1992 |
Methamphetamine. Stimulant of the 1990s?
Topics: Central Nervous System Diseases; Humans; Methamphetamine; Psychoses, Substance-Induced; Seizures; Substance-Related Disorders | 1990 |
On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats.
Topics: Amphetamine; Animals; Basal Ganglia; Caffeine; Catalepsy; Cocaine; Compulsive Behavior; Corpus Striatum; Disease Models, Animal; Dopamine; Hippocampus; Humans; Lysergic Acid Diethylamide; Methamphetamine; Methylphenidate; Morphine; Norepinephrine; Pemoline; Phenmetrazine; Psychoses, Substance-Induced; Rats; Reserpine; Thalamus; Tranquilizing Agents | 1972 |
The amphetamines: clinical and pharmacokinetic implications of recent studies of an assay procedure and urinary excretion in man.
Topics: Amphetamine; Chromatography, Gas; Humans; Hydrogen-Ion Concentration; Kinetics; Methamphetamine; Methods; Psychoses, Substance-Induced; Sulfates | 1966 |
The nature and extent of speed use in North America.
Topics: Female; Humans; Injections, Intravenous; Japan; Male; Methamphetamine; North America; Personality; Personality Disorders; Psychoses, Substance-Induced; Social Conditions; Substance-Related Disorders | 1970 |
10 trial(s) available for methamphetamine and Psychoses, Drug
Article | Year |
---|---|
How does a family history of psychosis influence the risk of methamphetamine-related psychotic symptoms: Evidence from longitudinal panel data.
Topics: Amphetamine-Related Disorders; Hallucinations; Humans; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Risk Factors | 2023 |
Electro-acupuncture improves psychiatric symptoms, anxiety and depression in methamphetamine addicts during abstinence: A randomized controlled trial.
Topics: Acupuncture Points; Adult; Anxiety; China; Depression; Electroacupuncture; Female; Humans; Male; Methamphetamine; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Single-Blind Method; Substance Withdrawal Syndrome | 2018 |
Treatment of methamphetamine-induced psychosis: a double-blind randomized controlled trial comparing haloperidol and quetiapine.
Topics: Adolescent; Adult; Age of Onset; Antipsychotic Agents; Central Nervous System Stimulants; Dibenzothiazepines; Double-Blind Method; Female; Haloperidol; Humans; Male; Methamphetamine; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Quetiapine Fumarate; Socioeconomic Factors; Survival Analysis; Young Adult | 2014 |
A randomized, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosis.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Aripiprazole; Behavior, Addictive; Double-Blind Method; Female; Humans; Male; Methamphetamine; Middle Aged; Patient Compliance; Piperazines; Psychoses, Substance-Induced; Quinolones | 2013 |
Monoamine neurotransmitter metabolites and spontaneous recurrence of methamphetamine psychosis.
Topics: Adult; Anxiety; Biogenic Monoamines; Female; Humans; Methamphetamine; Psychological Tests; Psychoses, Substance-Induced; Recurrence; Stress, Psychological | 1997 |
Methamphetamine toxicity: treatment with a benzodiazepine versus a butyrophenone.
Topics: Adult; Central Nervous System Stimulants; Conscious Sedation; Droperidol; Emergencies; Female; Hemodynamics; Humans; Lorazepam; Male; Methamphetamine; Prospective Studies; Psychoses, Substance-Induced; Tranquilizing Agents | 1997 |
Precipitating factors in spontaneous recurrence of methamphetamine psychosis.
Topics: Adult; Anxiety; Biogenic Monoamines; Dopamine Uptake Inhibitors; Female; Humans; Methamphetamine; Psychoses, Substance-Induced; Recurrence; Stress, Psychological; Substance-Related Disorders | 1997 |
Spontaneous recurrence of methampetamine psychosis: increased sensitivity to stress associated with noradrenergic hyperactivity and dopaminergic change.
Topics: Adaptation, Psychological; Adult; Analysis of Variance; Dopamine; Female; Humans; Methamphetamine; Norepinephrine; Prisoners; Psychoses, Substance-Induced; Recurrence; Stress, Psychological; Substance-Related Disorders | 1999 |
[Personality dependant changes in the experimental psychosis induced by lysergic acid diethylamide].
Topics: Adult; Clinical Trials as Topic; Euphoria; Fear; Female; Humans; Lysergic Acid Diethylamide; Meclofenoxate; Methamphetamine; Methylphenidate; Personality; Psychoses, Substance-Induced | 1966 |
Amphetamine abuse.
Topics: Acetylcholinesterase; Aggression; Amphetamine; Animals; Antisocial Personality Disorder; Behavior, Animal; Catecholamines; Child Behavior Disorders; Clinical Trials as Topic; Cocaine; Conditioning, Operant; Dextroamphetamine; Dopamine; Enzyme Induction; Hallucinogens; Humans; Methamphetamine; Mice; Mixed Function Oxygenases; Motor Activity; Narcolepsy; Norepinephrine; North Carolina; Paranoid Disorders; Psychoses, Substance-Induced; Rats; Substance-Related Disorders | 1971 |
206 other study(ies) available for methamphetamine and Psychoses, Drug
Article | Year |
---|---|
Characteristics of Amphetamine Psychosis with Respect to the Length of Drug Exposure.
Topics: Amphetamine; Humans; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Substance-Related Disorders | 2023 |
Application Prospect of Integrative Omics in Forensic Identification of Methamphetamine-Associated Psychosis.
Topics: Diagnosis, Differential; Humans; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Schizophrenia | 2022 |
Vigilance needed with methamphetamine-associated psychosis.
Topics: Central Nervous System Stimulants; Humans; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders | 2023 |
Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis.
Topics: Adult; Age of Onset; Amphetamine-Related Disorders; Brief Psychiatric Rating Scale; Central Nervous System Stimulants; Female; Humans; Male; Methamphetamine; Middle Aged; Paranoid Disorders; Psychoses, Substance-Induced; Psychotic Disorders; Schizophrenia; Severity of Illness Index; Time Factors | 2020 |
Comparisons of Voxel-Based Morphometric Brain Volumes of Individuals with Methamphetamine-Induced Psychotic Disorder and Schizophrenia Spectrum Disorder and Healthy Controls.
Topics: Adult; Amygdala; Atrophy; Central Nervous System Stimulants; Female; Gray Matter; Hippocampus; Humans; Limbic System; Male; Methamphetamine; Parahippocampal Gyrus; Psychoses, Substance-Induced; Putamen; Schizophrenia; White Matter; Young Adult | 2020 |
Lower folate levels in methamphetamine-induced psychosis: A cross-sectional study.
Topics: Adult; Amphetamine-Related Disorders; Biomarkers; Central Nervous System Stimulants; Cross-Sectional Studies; Female; Folic Acid; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Risk Factors | 2020 |
Direction of the relationship between methamphetamine use and positive psychotic symptoms in regular methamphetamine users: evidence from a prospective cohort study.
Topics: Adult; Amphetamine-Related Disorders; Australia; Female; Humans; Methamphetamine; Prospective Studies; Psychoses, Substance-Induced; Psychotic Disorders | 2021 |
Letter to the Editor-Is Chronic Methamphetamine-Induced Psychosis A Mental Disease for the Purposes of Insanity?
Topics: Amphetamine-Related Disorders; Central Nervous System Stimulants; Humans; Insanity Defense; Methamphetamine; Psychoses, Substance-Induced; Schizophrenia; United States | 2020 |
A latent class analysis of psychiatric symptom profiles associated with past-month methamphetamine use.
Topics: Amphetamine-Related Disorders; Hallucinations; Humans; Latent Class Analysis; Methamphetamine; Psychoses, Substance-Induced | 2021 |
Brain dysfunction of methamphetamine-associated psychosis in resting state: Approaching schizophrenia and critical role of right superior temporal deficit.
Topics: Adult; Amphetamine-Related Disorders; Brain Mapping; Female; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Patient Acuity; Psychoses, Substance-Induced; Schizophrenia; Temporal Lobe | 2021 |
Methamphetamine use and psychotic symptoms: findings from a New Zealand longitudinal birth cohort.
Topics: Adult; Amphetamine-Related Disorders; Birth Cohort; Child; Humans; Infant, Newborn; Longitudinal Studies; Methamphetamine; New Zealand; Psychoses, Substance-Induced; Psychotic Disorders; Risk Factors | 2023 |
Increased DNA methylation in the parvalbumin gene promoter is associated with methamphetamine dependence.
Topics: Adult; Amphetamine-Related Disorders; DNA Methylation; Humans; Male; Methamphetamine; Parvalbumins; Promoter Regions, Genetic; Psychoses, Substance-Induced | 2017 |
Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis.
Topics: Adult; Amphetamine-Related Disorders; Asian People; Brain-Derived Neurotrophic Factor; Case-Control Studies; Central Nervous System Stimulants; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Psychotic Disorders; Receptors, AMPA; Schizophrenia; Young Adult | 2018 |
DARK Side of Amphetamine and Analogues: Pharmacology, Syndromic Manifestation, and Management of Amphetamine Addiction.
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Brain; Cognition; Drug Tolerance; Humans; Methamphetamine; Mouth; Psychoses, Substance-Induced; Skin; Synapses; Tachyphylaxis | 2018 |
First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Delusions; Hallucinations; Humans; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Risk; Young Adult | 2018 |
The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Amphetamine; Amphetamine-Related Disorders; Australia; Female; Humans; Male; Methamphetamine; Middle Aged; Prospective Studies; Psychoses, Substance-Induced; Random Allocation; Schizophrenia; Young Adult | 2018 |
Relationship between the duration of methamphetamine use and psychotic symptoms: A two-year prospective cohort study.
Topics: Adult; Amphetamine-Related Disorders; China; Female; Humans; Male; Methamphetamine; Odds Ratio; Prospective Studies; Psychoses, Substance-Induced; Time Factors | 2018 |
Behavioral and Serotonergic Changes in the Frontal Cortex Following Methamphetamine Self-Administration.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Female; Frontal Lobe; Hallucinogens; Male; Methamphetamine; Psychoses, Substance-Induced; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT2; RNA-Binding Proteins; Self Administration; Serotonin; Time Factors | 2018 |
Changes in Gray Matter Density, Regional Homogeneity, and Functional Connectivity in Methamphetamine-Associated Psychosis: A Resting-State Functional Magnetic Resonance Imaging (fMRI) Study.
Topics: Adult; Brain; Brain Mapping; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Retrospective Studies; Schizophrenia; Young Adult | 2018 |
Increased BDNF-TrkB signaling in the nucleus accumbens plays a role in the risk for psychosis after cannabis exposure during adolescence.
Topics: Animals; Azepines; Behavior, Animal; Benzamides; Benzoxazines; Brain-Derived Neurotrophic Factor; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Central Nervous System Stimulants; Dentate Gyrus; Locomotion; Male; Marijuana Abuse; Membrane Glycoproteins; Methamphetamine; Mice; Mice, Inbred C57BL; Morpholines; Naphthalenes; Nucleus Accumbens; Prefrontal Cortex; Protein-Tyrosine Kinases; Psychoses, Substance-Induced; Risk | 2019 |
Effects of ketamine use on psychotic disorders and symptoms in male, methamphetamine-dependent subjects.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Humans; Ketamine; Male; Methamphetamine; Psychoses, Substance-Induced | 2019 |
Methamphetamine use in an early psychosis service: a cross-sectional retrospective cohort study.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Cross-Sectional Studies; Female; Humans; Male; Methamphetamine; Neuropsychological Tests; New South Wales; Psychoses, Substance-Induced; Retrospective Studies; Schizophrenia; Young Adult | 2019 |
Is there a discrete negative symptom syndrome in people who use methamphetamine?
Topics: Adult; Amphetamine-Related Disorders; Brief Psychiatric Rating Scale; Central Nervous System Stimulants; Diagnostic and Statistical Manual of Mental Disorders; Female; Hallucinations; Humans; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induced; Syndrome | 2019 |
Monitoring the prevalence of methamphetamine-related presentations at psychiatric hospitals in Cape Town, South Africa.
Topics: Adolescent; Adult; Aggression; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cross-Sectional Studies; Delusions; Developing Countries; Female; Hallucinations; Humans; Male; Methamphetamine; Middle Aged; Mood Disorders; Patient Admission; Patient Readmission; Psychoses, Substance-Induced; Schizophrenia; Sex Factors; South Africa; Urban Population; Young Adult | 2013 |
The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Comorbidity; Cross-Sectional Studies; Female; Humans; Malaysia; Male; Methamphetamine; Psychoses, Substance-Induced; Risk Factors | 2014 |
A sex- and region-specific role of Akt1 in the modulation of methamphetamine-induced hyperlocomotion and striatal neuronal activity: implications in schizophrenia and methamphetamine-induced psychosis.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Disease Models, Animal; Estradiol; Estrogens; Female; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Neostriatum; Neurons; Proto-Oncogene Proteins c-akt; Psychoses, Substance-Induced; Raclopride; Schizophrenia; Sex Factors | 2014 |
Enacting multiple methamphetamines: the ontological politics of public discourse and consumer accounts of a drug and its effects.
Topics: Amphetamine-Related Disorders; Australia; Health Policy; Humans; Methamphetamine; Psychoses, Substance-Induced; Research | 2013 |
Association of a functional FAAH polymorphism with methamphetamine-induced symptoms and dependence in a Malaysian population.
Topics: Adult; Amidohydrolases; Amphetamine-Related Disorders; Case-Control Studies; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Methamphetamine; Panic Disorder; Phenotype; Polymorphism, Genetic; Psychoses, Substance-Induced; Substance-Related Disorders | 2013 |
Methamphetamine-related psychiatric visits to an urban academic emergency department: an observational study.
Topics: Adult; Age Factors; Amphetamine-Related Disorders; Anxiety; Chest Pain; Depression; Dyspnea; Emergency Service, Hospital; Emergency Services, Psychiatric; Female; Headache; Hospitals, University; Humans; Insurance, Health; Male; Mental Disorders; Methamphetamine; Middle Aged; Nausea; Psychoses, Substance-Induced; Seizures; Suicidal Ideation; Urban Health Services; Vomiting; Wounds and Injuries; Young Adult | 2013 |
Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia.
Topics: Alleles; Amphetamine-Related Disorders; Asian People; Case-Control Studies; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Methamphetamine; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Schizophrenia | 2013 |
[Clinical characteristics of dappou herb use--disorder patients at the drug dependence clinic: a comparison with methamphetamine use-disorder patients].
Topics: Adolescent; Adult; Antisocial Personality Disorder; Humans; Illicit Drugs; Japan; Male; Methamphetamine; Outpatients; Psychoses, Substance-Induced; Substance-Related Disorders; Young Adult | 2013 |
Genetic variation of GRIN1 confers vulnerability to methamphetamine-dependent psychosis in a Thai population.
Topics: Adult; Case-Control Studies; Genetic Association Studies; Humans; Male; Methamphetamine; Middle Aged; Nerve Tissue Proteins; Polymorphism, Genetic; Psychoses, Substance-Induced; Receptors, N-Methyl-D-Aspartate; Risk Factors; Thailand; Young Adult | 2013 |
Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.
Topics: Adult; Amphetamine-Related Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Interviews as Topic; Male; Methamphetamine; Middle Aged; Predictive Value of Tests; Psychoses, Substance-Induced; Surveys and Questionnaires | 2013 |
Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study.
Topics: Adult; Alcohol Drinking; Amphetamine-Related Disorders; Australia; Causality; Cohort Studies; Female; Humans; Longitudinal Studies; Male; Methamphetamine; Prospective Studies; Psychoses, Substance-Induced; Risk Factors; Violence; Young Adult | 2014 |
Clinical features of methamphetamine-induced paranoia and preliminary genetic association with DBH-1021C→T in a Thai treatment cohort.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Dopamine beta-Hydroxylase; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Male; Methamphetamine; Middle Aged; Paranoid Disorders; Polymorphism, Restriction Fragment Length; Psychoses, Substance-Induced; Thailand; Young Adult | 2014 |
Adverse childhood experiences and interaction with methamphetamine use frequency in the risk of methamphetamine-associated psychosis.
Topics: Adolescent; Adult; Adult Survivors of Child Abuse; Amphetamine-Related Disorders; Child of Impaired Parents; Cross-Sectional Studies; Female; Humans; Life Change Events; Male; Methamphetamine; Psychoses, Substance-Induced; Risk Factors; Young Adult | 2014 |
Reaction time variability and related brain activity in methamphetamine psychosis.
Topics: Adult; Amphetamine-Related Disorders; Brain; Brain Mapping; Central Nervous System Stimulants; Cognition; Executive Function; Female; Humans; Individuality; Magnetic Resonance Imaging; Male; Methamphetamine; Psychoses, Substance-Induced; Reaction Time; Stroop Test | 2015 |
Characterizing prefrontal cortical activity during inhibition task in methamphetamine-associated psychosis versus schizophrenia: a multi-channel near-infrared spectroscopy study.
Topics: Adult; Amphetamine-Related Disorders; Analysis of Variance; Case-Control Studies; Central Nervous System Stimulants; Female; Hemoglobins; Humans; Inhibition, Psychological; Male; Methamphetamine; Neuropsychological Tests; Oxyhemoglobins; Prefrontal Cortex; Psychomotor Performance; Psychoses, Substance-Induced; Schizophrenia; Spectroscopy, Near-Infrared | 2016 |
[Amphetamine-induced psychosis or schizophrenia?].
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Humans; Methamphetamine; Psychoses, Substance-Induced; Risk Factors; Schizophrenia; Schizophrenic Psychology | 2015 |
Primary and substance-induced psychotic disorders in methamphetamine users.
Topics: Adult; Age of Onset; Amphetamine-Related Disorders; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Symptom Assessment; Young Adult | 2015 |
Typologies of positive psychotic symptoms in methamphetamine dependence.
Topics: Adult; Amphetamine-Related Disorders; Delusions; Female; Hallucinations; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Symptom Assessment; Victoria; Young Adult | 2015 |
BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence.
Topics: Amphetamine-Related Disorders; Asian People; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Diagnostic and Statistical Manual of Mental Disorders; Gene Frequency; Genotype; Humans; Methamphetamine; Polymorphism, Genetic; Psychoses, Substance-Induced; Thailand | 2015 |
BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine.
Topics: Amphetamine-Related Disorders; Animals; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Male; Methamphetamine; Mice, Transgenic; Motor Activity; Psychoses, Substance-Induced | 2016 |
The profile of psychiatric symptoms exacerbated by methamphetamine use.
Topics: Adult; Amphetamine-Related Disorders; Behavioral Symptoms; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Longitudinal Studies; Male; Mental Disorders; Methamphetamine; Psychoses, Substance-Induced; Symptom Assessment | 2016 |
Clinical features, course and treatment of methamphetamine-induced psychosis in psychiatric inpatients.
Topics: Adult; Amphetamine-Related Disorders; Brief Psychiatric Rating Scale; Delusions; Electroconvulsive Therapy; Female; Hallucinations; Humans; Inpatients; Iran; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induced; Suicide | 2016 |
White matter microstructure and impulsivity in methamphetamine dependence with and without a history of psychosis.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Brain; Central Nervous System Stimulants; Diffusion Tensor Imaging; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Impulsive Behavior; Male; Methamphetamine; Pattern Recognition, Automated; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Surveys and Questionnaires; White Matter; Young Adult | 2016 |
Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users.
Topics: Adult; Age Factors; Amphetamine-Related Disorders; Anxiety Disorders; Brief Psychiatric Rating Scale; Comorbidity; Conduct Disorder; Depressive Disorder, Major; Female; Hallucinations; Humans; Longitudinal Studies; Male; Methamphetamine; Prospective Studies; Psychoses, Substance-Induced; Psychotic Disorders; Risk Factors; Sex Factors | 2016 |
Factors affecting severity of positive and negative symptoms of psychosis in a polysubstance using population with psychostimulant dependence.
Topics: Adult; Amphetamine-Related Disorders; Canada; Central Nervous System Stimulants; Cocaine-Related Disorders; Cross-Sectional Studies; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Marijuana Smoking; Methamphetamine; Middle Aged; Psychoses, Substance-Induced; Severity of Illness Index | 2016 |
Candidate gene networks and blood biomarkers of methamphetamine-associated psychosis: an integrative RNA-sequencing report.
Topics: Adult; Amphetamine-Related Disorders; Biomarkers; Brain; Female; Gene Regulatory Networks; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Psychoses, Substance-Induced; Sequence Analysis, RNA; Young Adult | 2016 |
Demographic and mental history-related data predicted occurrence of psychosis in metamphetamine users.
Topics: Adult; Amphetamine-Related Disorders; Female; Hospitalization; Humans; Incidence; Iran; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induced; Young Adult | 2016 |
Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population.
Topics: Adult; Amphetamine-Related Disorders; Australia; Brief Psychiatric Rating Scale; Female; Humans; Interviews as Topic; Male; Methamphetamine; Prevalence; Psychoses, Substance-Induced; Risk Factors; Risk-Taking; Self Report | 2016 |
Clinical Course of Methamphetamine-Induced Psychotic Disorder in a 3-Month Follow-Up.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Female; Follow-Up Studies; Hospitalization; Humans; Interview, Psychological; Male; Methamphetamine; Patient Compliance; Prognosis; Prospective Studies; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Recurrence; Regression Analysis; Time Factors; Treatment Outcome | 2016 |
First-Rank Symptoms in Methamphetamine Psychosis and Schizophrenia.
Topics: Adult; Delusions; Female; Hallucinations; Humans; Logistic Models; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induced; Psychotic Disorders; Schizophrenia | 2016 |
Twelve-month course and outcome of methamphetamine-induced psychosis compared with first episode primary psychotic disorders.
Topics: Adult; Case-Control Studies; Female; Humans; Male; Methamphetamine; Prognosis; Prospective Studies; Psychoses, Substance-Induced; Psychotic Disorders; Young Adult | 2018 |
Factors associated with readmission in South African adolescents discharged from two inpatient psychosocial rehabilitation units.
Topics: Adolescent; Alcoholism; Amphetamine-Related Disorders; Bipolar Disorder; Cohort Studies; Educational Status; Female; Hospital Units; Humans; Male; Marijuana Abuse; Methamphetamine; Multivariate Analysis; Patient Readmission; Psychiatric Rehabilitation; Psychoses, Substance-Induced; Retrospective Studies; Risk Factors; Schizophrenia; South Africa; Young Adult | 2016 |
A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cocaine-Related Disorders; Cohort Studies; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Humans; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induced | 2017 |
Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
Topics: Adult; Amphetamine-Related Disorders; Brief Psychiatric Rating Scale; Delusions; Diagnosis, Differential; Diagnostic and Statistical Manual of Mental Disorders; Female; Hallucinations; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Substance Abuse, Intravenous | 2017 |
An exploratory analysis of neurocognition in methamphetamine-induced psychotic disorder and paranoid schizophrenia.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cognition Disorders; Diagnosis, Differential; Female; Humans; Male; Methamphetamine; Neuropsychological Tests; Psychometrics; Psychoses, Substance-Induced; Reproducibility of Results; Schizophrenia, Paranoid | 2008 |
Profiles associated with treatment retention in Japanese patients with methamphetamine use disorder: preliminary survey.
Topics: Adult; Ambulatory Care; Amphetamine-Related Disorders; Crime; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Japan; Male; Methamphetamine; Middle Aged; Patient Admission; Patient Dropouts; Prisoners; Psychiatric Department, Hospital; Psychoses, Substance-Induced; Public Assistance; Socioeconomic Factors; Young Adult | 2008 |
Association study between casein kinase 1 epsilon gene and methamphetamine dependence.
Topics: Adult; Amphetamine-Related Disorders; Animals; Asian People; Casein Kinase 1 epsilon; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Uptake Inhibitors; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methamphetamine; Mice; Middle Aged; Phenotype; Polymorphism, Genetic; Psychoses, Substance-Induced; Second Messenger Systems | 2008 |
Short allele of 5-HTTLPR as a risk factor for the development of psychosis in Japanese methamphetamine abusers.
Topics: Adult; Aged; Asian People; Central Nervous System Stimulants; Drug Users; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methamphetamine; Middle Aged; Polymorphism, Genetic; Psychoses, Substance-Induced; Receptor, Serotonin, 5-HT1A; Risk Factors; Serotonin Plasma Membrane Transport Proteins; Young Adult | 2008 |
Association study of the calcineurin A gamma subunit gene (PPP3CC) and methamphetamine-use disorder in a Japanese population.
Topics: Amphetamine-Related Disorders; Asian People; Calcineurin; Case-Control Studies; Central Nervous System Stimulants; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Methamphetamine; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Schizophrenia | 2008 |
Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population.
Topics: Adult; Amphetamine-Related Disorders; Asian People; Female; Genotype; Glutamate-Cysteine Ligase; Humans; Linkage Disequilibrium; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Protein Subunits; Psychoses, Substance-Induced; Schizophrenia | 2008 |
Alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes are not associated with methamphetamine-use disorder in the Japanese population.
Topics: Adult; Amphetamine-Related Disorders; Asian People; Central Nervous System Stimulants; Female; Genotype; Haplotypes; Humans; Linkage Disequilibrium; Male; Methamphetamine; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Protein Subunits; Psychoses, Substance-Induced; Receptors, Nicotinic | 2008 |
Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users.
Topics: Adult; Amphetamine-Related Disorders; Australia; Central Nervous System Stimulants; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Male; Methamphetamine; Neural Pathways; Psychoses, Substance-Induced; Risk Factors | 2009 |
Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis.
Topics: Adult; Case-Control Studies; Central Nervous System Stimulants; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genotype; Glycine; Humans; Male; Methamphetamine; Middle Aged; Minisatellite Repeats; Prognosis; Psychoses, Substance-Induced; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Serine; Statistics, Nonparametric | 2009 |
An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosis.
Topics: Adolescent; Adult; Aged; Dopamine Agents; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; Methamphetamine; Middle Aged; Monoamine Oxidase; Polymorphism, Genetic; Psychoses, Substance-Induced; Sex Factors; Substance-Related Disorders; Young Adult | 2009 |
A functional polymorphism in estrogen receptor alpha gene is associated with Japanese methamphetamine induced psychosis.
Topics: Adult; Amphetamine-Related Disorders; Asian People; Case-Control Studies; Estrogen Receptor alpha; Female; Gene Frequency; Humans; Male; Methamphetamine; Middle Aged; Polymorphism, Genetic; Psychoses, Substance-Induced | 2009 |
Genetic association analysis of NRG1 with methamphetamine-induced psychosis in a Japanese population.
Topics: Adult; Amphetamine-Related Disorders; Asian People; Female; Gene Frequency; Genome-Wide Association Study; Humans; Male; Methamphetamine; Middle Aged; Neuregulin-1; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Young Adult | 2009 |
G72 gene is associated with susceptibility to methamphetamine psychosis.
Topics: Adult; Carrier Proteins; Case-Control Studies; Female; Genetic Predisposition to Disease; Humans; Intracellular Signaling Peptides and Proteins; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Psychotic Disorders | 2009 |
Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients.
Topics: Adult; Amphetamine-Related Disorders; Asian People; Case-Control Studies; Central Nervous System Stimulants; Female; Genetic Association Studies; Genotype; Humans; Japan; Linkage Disequilibrium; Male; Methamphetamine; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Receptor, Serotonin, 5-HT1A; Sequence Analysis, DNA | 2010 |
Occurrence of comorbid substance use disorders among acute psychiatric inpatients at Stikland Hospital in the Western Cape, South Africa.
Topics: Adolescent; Adult; Aged; Amphetamine-Related Disorders; Commitment of Mentally Ill; Comorbidity; Cross-Sectional Studies; Diagnosis, Dual (Psychiatry); Female; Hospitals, Psychiatric; Hospitals, State; Humans; Illicit Drugs; Male; Marijuana Abuse; Mental Disorders; Methamphetamine; Middle Aged; Patient Admission; Psychoses, Substance-Induced; South Africa; Substance Abuse Detection; Substance-Related Disorders; Violence; Young Adult | 2009 |
Deterioration of intelligence in methamphetamine-induced psychosis: comparison with alcohol dependence on WAIS-III.
Topics: Adult; Age of Onset; Alcoholism; Amphetamine-Related Disorders; Central Nervous System Stimulants; Female; Humans; Intelligence; Language; Male; Memory, Short-Term; Methamphetamine; Psychomotor Performance; Psychoses, Substance-Induced; Wechsler Scales | 2010 |
Association analysis of GRM2 and HTR2A with methamphetamine-induced psychosis and schizophrenia in the Japanese population.
Topics: Amphetamine-Related Disorders; Asian People; Case-Control Studies; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Japan; Methamphetamine; Mutation; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Receptor, Serotonin, 5-HT2A; Receptors, Metabotropic Glutamate; Regression Analysis; Schizophrenia | 2010 |
Norzotepine, a major metabolite of zotepine, exerts atypical antipsychotic-like and antidepressant-like actions through its potent inhibition of norepinephrine reuptake.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antipsychotic Agents; Apomorphine; Body Temperature; Catalepsy; Cell Line; Central Nervous System Stimulants; CHO Cells; Cricetinae; Cricetulus; Dibenzothiepins; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Norepinephrine; Psychoses, Substance-Induced; Reserpine; Swimming | 2010 |
Serotonin 6 receptor gene is associated with methamphetamine-induced psychosis in a Japanese population.
Topics: Amphetamine-Related Disorders; Asian People; Central Nervous System Stimulants; Female; Genome-Wide Association Study; Genotype; Haplotypes; Humans; Male; Methamphetamine; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Receptors, Serotonin | 2011 |
Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants.
Topics: Adult; Amphetamine-Related Disorders; Body Dysmorphic Disorders; Chi-Square Distribution; Cocaine-Related Disorders; Delusions; Female; Hallucinations; Humans; Linear Models; Male; Methamphetamine; Middle Aged; Paranoid Disorders; Prevalence; Psychoses, Substance-Induced; Sex Factors; Surveys and Questionnaires | 2010 |
Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis.
Topics: Adult; Affect; Amphetamine-Related Disorders; Anxiety; Central Nervous System Stimulants; Data Interpretation, Statistical; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Methamphetamine; Motivation; Outpatients; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Schizophrenic Psychology; Speech | 2011 |
Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Corpus Striatum; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Haloperidol; Long-Term Care; Male; Methamphetamine; Motor Activity; Piperazines; Psychoses, Substance-Induced; Quinolones; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Schizophrenia | 2012 |
No significant association between SIRT1 gene and methamphetamine-induced psychosis in the Japanese population.
Topics: Adult; Asian People; Case-Control Studies; Central Nervous System Stimulants; Databases, Genetic; Humans; Japan; Linkage Disequilibrium; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Sirtuin 1; Young Adult | 2011 |
Mitigating the risks of methamphetamine.
Topics: Amphetamine-Related Disorders; Emergency Service, Hospital; Humans; Methamphetamine; Psychoses, Substance-Induced; Safety Management; United Kingdom; Violence | 2011 |
"Bath salt" ingestion leading to severe intoxication delirium: two cases and a brief review of the emergence of mephedrone use.
Topics: Adult; Delirium; Designer Drugs; Humans; Illicit Drugs; Male; Methamphetamine; Psychoses, Substance-Induced | 2012 |
Bath salts: they are not what you think.
Topics: Benzodioxoles; Central Nervous System Stimulants; Cross-Sectional Studies; Designer Drugs; Drug and Narcotic Control; Female; Humans; Illicit Drugs; Male; Methamphetamine; Middle Aged; Paranoid Disorders; Psychoses, Substance-Induced; Pyrrolidines; Substance Abuse Detection; Substance-Related Disorders; Synthetic Cathinone | 2012 |
Three fatal intoxications due to methylone.
Topics: Acidosis; Adult; Central Nervous System Stimulants; Fatal Outcome; Female; Fever; Humans; Illicit Drugs; Male; Methamphetamine; Psychoses, Substance-Induced; Seizures; Young Adult | 2012 |
Intoxication delirium following use of synthetic cathinone derivatives.
Topics: Delirium; Designer Drugs; Humans; Illicit Drugs; Male; Methamphetamine; Psychoses, Substance-Induced | 2012 |
Dependence and psychosis with 4-methylmethcathinone (mephedrone) use.
Topics: Adult; Amphetamine-Related Disorders; Humans; Illicit Drugs; Male; Methamphetamine; Psychoses, Substance-Induced | 2010 |
"Bath salts"-induced psychosis and serotonin toxicity.
Topics: Administration, Inhalation; Adult; Alkaloids; Catha; Central Nervous System Stimulants; Diagnosis, Differential; Emergency Service, Hospital; Female; Humans; Mental Status Schedule; Methamphetamine; Psychoses, Substance-Induced; Pyrrolidines; Serotonin; Serotonin Syndrome | 2012 |
Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
Topics: Adult; Alcohol Drinking; Amphetamine-Related Disorders; Australia; Central Nervous System Stimulants; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Longitudinal Studies; Male; Marijuana Smoking; Methamphetamine; Odds Ratio; Prospective Studies; Psychoses, Substance-Induced; Psychotic Disorders; Risk Factors | 2013 |
Clinical features of inpatients with methamphetamine-induced psychosis.
Topics: Adult; Amphetamine-Related Disorders; Female; Hospitalization; Humans; Iran; Male; Methamphetamine; Psychoses, Substance-Induced | 2013 |
Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region.
Topics: Asia, Southeastern; Central Nervous System Stimulants; Humans; Methamphetamine; Psychoses, Substance-Induced; Public Health | 2002 |
Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration.
Topics: Adolescent; Adult; Analysis of Variance; Central Nervous System Stimulants; Chi-Square Distribution; Female; Humans; Japan; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induced; Smoking; Social Environment; Substance Abuse, Intravenous; Substance-Related Disorders | 2002 |
Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis.
Topics: Adult; Amphetamine-Related Disorders; Dopamine Plasma Membrane Transport Proteins; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Minisatellite Repeats; Nerve Tissue Proteins; Polymorphism, Genetic; Psychoses, Substance-Induced | 2003 |
Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms.
Topics: Adult; Amphetamine-Related Disorders; Amygdala; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Frontal Lobe; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Nerve Tissue Proteins; Prefrontal Cortex; Psychoses, Substance-Induced; Tomography, Emission-Computed | 2003 |
Acute psychotic reaction after inhaling methylamphetamine.
Topics: Amphetamine; Amphetamines; Humans; Mental Disorders; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders | 1954 |
REACTIONS TO USE OF AMPHETAMINES AS OBSERVED IN A PSYCHIATRIC HOSPITAL.
Topics: Alcoholism; Amobarbital; Amphetamine; Amphetamines; Barbiturates; Dextroamphetamine; Hospitals, Psychiatric; Humans; Methamphetamine; Narcotics; Paranoid Disorders; Phenmetrazine; Psychoses, Substance-Induced; Psychotic Disorders; Schizophrenia; Substance Withdrawal Syndrome; Substance-Related Disorders; Toxicology | 1964 |
Susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Female; Humans; Methamphetamine; Psychoses, Substance-Induced; Secondary Prevention; Statistics, Nonparametric | 2003 |
Psychotic symptoms in methamphetamine psychotic in-patients.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Anxiety Disorders; Australia; Central Nervous System Stimulants; Cross-Cultural Comparison; Cross-Sectional Studies; Delusions; Depressive Disorder; Female; Hallucinations; Humans; Japan; Male; Methamphetamine; Patient Admission; Philippines; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Thailand | 2003 |
Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis.
Topics: Adolescent; Adult; Alcoholism; Amphetamine-Related Disorders; Antisocial Personality Disorder; Causality; Central Nervous System Stimulants; Comorbidity; Depressive Disorder, Major; Disease Susceptibility; Female; Hospitals, Psychiatric; Humans; Male; Methamphetamine; Personality Assessment; Prisons; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Risk Factors; Schizoid Personality Disorder; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Taiwan | 2003 |
[The relation between behavioral sensitization and glutamate release on the animal model of methamphetamine-induced psychosis].
Topics: Animals; Behavior, Animal; Dopamine; Glutamic Acid; Male; Methamphetamine; Models, Animal; Nucleus Accumbens; Psychoses, Substance-Induced; Rats; Rats, Wistar | 2004 |
DAT polymorphism and diverse clinical manifestations in methamphetamine abusers.
Topics: 3' Untranslated Regions; Acute Disease; Adult; Alleles; Amphetamine-Related Disorders; Asian People; China; Chronic Disease; Dopamine Plasma Membrane Transport Proteins; Female; Gene Frequency; Genotype; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Minisatellite Repeats; Nerve Tissue Proteins; Polymorphism, Genetic; Psychoses, Substance-Induced; Taiwan | 2004 |
Neuromechanism of developing methamphetamine psychosis: a neuroimaging study.
Topics: Adult; Amphetamine-Related Disorders; Female; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Positron-Emission Tomography; Protein Binding; Psychoses, Substance-Induced; Tomography, Emission-Computed, Single-Photon | 2004 |
The role of noradrenergic and dopaminergic hyperactivity in the development of spontaneous recurrence of methamphetamine psychosis and susceptibility to episode recurrence.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Disease Susceptibility; Dopamine; Female; Humans; Methamphetamine; Norepinephrine; Psychoses, Substance-Induced; Secondary Prevention; Statistics, Nonparametric; Stress, Physiological | 2004 |
A polymorphism of DRD2 gene and brain atrophy in methamphetamine psychosis.
Topics: Adult; Atrophy; Brain; Genotype; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Middle Aged; Polymorphism, Genetic; Psychoses, Substance-Induced; Receptors, Dopamine D2 | 2004 |
Study of association between alpha-synuclein gene polymorphism and methamphetamine psychosis/dependence.
Topics: Adult; alpha-Synuclein; Amphetamine-Related Disorders; Chi-Square Distribution; Female; Gene Frequency; Humans; Male; Methamphetamine; Middle Aged; Monte Carlo Method; Nerve Tissue Proteins; Polymorphism, Genetic; Psychoses, Substance-Induced; Synucleins | 2004 |
[Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cross-Sectional Studies; Diagnosis, Differential; Forecasting; Germany; Humans; Methamphetamine; Paranoid Disorders; Psychoses, Substance-Induced; Schizophrenia | 2005 |
A functional glutathione S-transferase P1 gene polymorphism is associated with methamphetamine-induced psychosis in Japanese population.
Topics: Adolescent; Adult; Aged; Alleles; Amphetamine-Related Disorders; Female; Gene Frequency; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Japan; Male; Methamphetamine; Middle Aged; Polymorphism, Genetic; Psychoses, Substance-Induced | 2005 |
[A validation of the applicability of the Severity of Dependence Scale (SDS) in a nationwide mental hospital survey on substance-related psychiatric disorders].
Topics: Adult; Data Collection; Female; Humans; Japan; Male; Methamphetamine; Psychoses, Substance-Induced; Severity of Illness Index | 2005 |
HIV-associated medical, behavioral, and psychiatric characteristics of treatment-seeking, methamphetamine-dependent men who have sex with men.
Topics: Adult; Amphetamine-Related Disorders; Behavior Therapy; Comorbidity; Cross-Sectional Studies; HIV Seropositivity; Homosexuality, Male; Humans; Los Angeles; Male; Mental Disorders; Methamphetamine; Multivariate Analysis; Patient Acceptance of Health Care; Patient Admission; Psychoses, Substance-Induced; Risk-Taking; Sexual Behavior; Statistics as Topic; Substance Abuse, Intravenous; Substance-Related Disorders; Unsafe Sex | 2005 |
Functional polymorphism of the NQO2 gene is associated with methamphetamine psychosis.
Topics: Adult; Central Nervous System Stimulants; DNA Primers; Female; Gene Expression; Genotype; Humans; Male; Methamphetamine; Point Mutation; Polymorphism, Genetic; Promoter Regions, Genetic; Psychoses, Substance-Induced; Quinone Reductases; Restriction Mapping | 2005 |
Drug-induced psychosis associated with crystalline methamphetamine.
Topics: Adult; Antipsychotic Agents; Dibenzothiazepines; Female; Humans; Methamphetamine; Psychoses, Substance-Induced; Quetiapine Fumarate | 2006 |
Selective serotonin reuptake inhibitors, fluoxetine and paroxetine, attenuate the expression of the established behavioral sensitization induced by methamphetamine.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Fluoxetine; Head Movements; Locomotion; Methamphetamine; Mice; Paroxetine; Psychoses, Substance-Induced; Secondary Prevention; Selective Serotonin Reuptake Inhibitors | 2007 |
Association analysis of delta-opioid receptor gene polymorphisms in methamphetamine dependence/psychosis.
Topics: Adult; Alleles; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Japan; Linkage Disequilibrium; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Receptors, Opioid, delta | 2006 |
Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations.
Topics: Adolescent; Adult; Aged; Amino Acid Substitution; Amphetamine-Related Disorders; Asian People; Case-Control Studies; Exons; Haplotypes; Humans; Japan; Linkage Disequilibrium; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Superoxide Dismutase; Taiwan | 2006 |
Combined intoxication with methylone and 5-MeO-MIPT.
Topics: Adult; Akathisia, Drug-Induced; Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Substance-Related Disorders; Tryptamines | 2007 |
The prevalence of psychotic symptoms among methamphetamine users.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Brief Psychiatric Rating Scale; Central Nervous System Stimulants; Cross-Sectional Studies; Female; Humans; Male; Methamphetamine; Middle Aged; New South Wales; Prevalence; Psychoses, Substance-Induced | 2006 |
Peroxisome proliferator-activated receptor gamma activation relieves expression of behavioral sensitization to methamphetamine in mice.
Topics: Amphetamine-Related Disorders; Anilides; Animals; Behavior, Animal; Brain; Brain Chemistry; Cell Nucleus; Disease Models, Animal; Dopamine Uptake Inhibitors; Electrophoretic Mobility Shift Assay; Encephalitis; Hypoglycemic Agents; Male; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Nucleus Accumbens; Pioglitazone; PPAR gamma; Psychoses, Substance-Induced; Retinoid X Receptors; Reward; Thiazolidinediones | 2007 |
Crystal crush.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Emergency Service, Hospital; Emergency Services, Psychiatric; Humans; Illicit Drugs; Methamphetamine; Northwestern United States; Pharmacies; Prevalence; Psychoses, Substance-Induced; Security Measures; United States | 2006 |
Ice: cool drug or real problem?
Topics: Amphetamine-Related Disorders; Australia; Central Nervous System Stimulants; Drug and Narcotic Control; Humans; Illicit Drugs; Methamphetamine; Psychoses, Substance-Induced; Substance Abuse Treatment Centers | 2007 |
Amphetamine-related presentations to an inner-city tertiary emergency department: a prospective evaluation.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Amphetamine-Related Disorders; Australia; Central Nervous System Stimulants; Cohort Studies; Delirium; Emergency Service, Hospital; Female; Heart Rate; Humans; Hypnotics and Sedatives; Illicit Drugs; Male; Methamphetamine; Middle Aged; Patient Admission; Prospective Studies; Psychoses, Substance-Induced; Time Factors; Urban Health Services | 2007 |
Hospital separations for cannabis- and methamphetamine-related psychotic episodes in Australia.
Topics: Adolescent; Adult; Age Factors; Amphetamine-Related Disorders; Australia; Child; Databases as Topic; Hospitalization; Humans; Marijuana Abuse; Methamphetamine; Middle Aged; Population Surveillance; Prevalence; Prospective Studies; Psychoses, Substance-Induced | 2007 |
The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis.
Topics: Adult; Carrier Proteins; Case-Control Studies; DNA Mutational Analysis; Dysbindin; Dystrophin-Associated Proteins; Female; Genetic Predisposition to Disease; Humans; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Statistics, Nonparametric | 2008 |
The glycine transporter 1 gene (GLYT1) is associated with methamphetamine-use disorder.
Topics: Adult; Amphetamine-Related Disorders; Case-Control Studies; Female; Genetic Predisposition to Disease; Genotype; Glycine Plasma Membrane Transport Proteins; Humans; Male; Methamphetamine; Middle Aged; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced | 2008 |
Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis.
Topics: Adolescent; Adult; Aged; Amphetamine-Related Disorders; Asian People; Carrier Proteins; Dopamine Plasma Membrane Transport Proteins; Female; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Inteins; Japan; Male; Methamphetamine; Middle Aged; Nuclear Proteins; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prognosis; Promoter Regions, Genetic; Psychoses, Substance-Induced; Transcription Factors | 2007 |
Analysis of association of clinical correlates and 5-HTTLPR polymorphism with suicidal behavior among Chinese methamphetamine abusers.
Topics: Adult; Alleles; Amphetamine-Related Disorders; Asian People; Comorbidity; Depressive Disorder; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Methamphetamine; Polymorphism, Genetic; Promoter Regions, Genetic; Psychoses, Substance-Induced; Risk Factors; Serotonin Plasma Membrane Transport Proteins; Statistics as Topic; Suicide, Attempted; Taiwan | 2007 |
Preliminary evidence of behavioral predictors of recurrent drug-induced psychosis in methamphetamine abuse.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Female; Humans; Male; Methamphetamine; Prefrontal Cortex; Psychomotor Agitation; Psychoses, Substance-Induced | 2008 |
Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam.
Topics: Aged; Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Biperiden; Central Nervous System Stimulants; Clonazepam; Dyskinesia, Drug-Induced; Hallucinations; Haloperidol; Humans; Male; Methamphetamine; Olanzapine; Posture; Psychoses, Substance-Induced; Risperidone | 2007 |
Effects of methamphetamine on single unit activity in rat medial prefrontal cortex in vivo.
Topics: Action Potentials; Animals; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Male; Methamphetamine; Neurons; Prefrontal Cortex; Psychoses, Substance-Induced; Rats; Rats, Sprague-Dawley; Schizophrenia; Stochastic Processes; Synaptic Transmission | 2007 |
Reduction of 3H-kainic acid binding in rat cerebral cortex by chronic methamphetamine administration.
Topics: Animals; Cerebral Cortex; Frontal Lobe; Humans; Kainic Acid; Male; Membranes; Methamphetamine; Psychoses, Substance-Induced; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Glutamate; Receptors, Neurotransmitter | 1984 |
[Multiphasic clinical types of methamphetamine psychosis and its dependence].
Topics: Adolescent; Adult; Female; Humans; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induced; Substance-Related Disorders | 1984 |
[A case of acute recurrent methamphetamine psychosis characterized by fancy delusions of grandeur].
Topics: Adult; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Substance-Related Disorders | 1984 |
Amphetamine psychosis in Tokyo--its clinical features and social problems.
Topics: Acute Disease; Adult; Amphetamine; Chronic Disease; Diagnosis, Differential; Female; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Social Problems; Socioeconomic Factors; Tokyo | 1983 |
Long-lasting hypersensitivity to methamphetamine following amygdaloid kindling in cats: the relationship between limbic epilepsy and the psychotic state.
Topics: Amygdala; Animals; Arousal; Carrier Proteins; Cats; Dose-Response Relationship, Drug; Heart Rate; Humans; Kindling, Neurologic; Limbic System; Methamphetamine; Piloerection; Pimozide; Psychoses, Substance-Induced; Receptors, Adrenergic; Respiration; Salivation; Seizures; Stereotyped Behavior | 1983 |
Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis.
Topics: Adult; Delusions; Hallucinations; Haloperidol; Humans; Male; Methamphetamine; Paranoid Disorders; Psychoses, Substance-Induced; Recurrence; Schizophrenia, Paranoid; Schizophrenic Psychology; Substance Withdrawal Syndrome; Triflupromazine | 1983 |
Mania occurring during treatment for depersonalization: a report of two cases.
Topics: Adolescent; Adult; Antidepressive Agents; Bipolar Disorder; Depersonalization; Female; Humans; Methamphetamine; Psychoses, Substance-Induced | 1980 |
Spontaneous recurrence of methamphetamine psychosis: process and monoamine neurotransmitter function.
Topics: Adult; Biogenic Monoamines; Female; Humans; Methamphetamine; Neurotransmitter Agents; Psychoses, Substance-Induced; Recurrence | 1995 |
Reduced attention-related negative potentials in methamphetamine psychosis.
Topics: Adult; Attention; Auditory Perception; Diagnosis, Differential; Discrimination, Psychological; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Male; Methamphetamine; Middle Aged; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Reaction Time; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1995 |
Effect of a single injection of psychoactive drugs on CCK mRNA in rat brain.
Topics: Animals; Brain Chemistry; Cholecystokinin; Disease Models, Animal; Male; Methamphetamine; Phencyclidine; Psychoses, Substance-Induced; Rats; Rats, Wistar; RNA, Messenger | 1994 |
P300 component of event-related potentials in methamphetamine psychosis and schizophrenia.
Topics: Adult; Discrimination, Psychological; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Male; Methamphetamine; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Reaction Time; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1994 |
Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report.
Topics: Adolescent; Adult; Female; Hospitals, Psychiatric; Humans; Japan; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induced | 1994 |
Event-related potentials in methamphetamine psychosis during an auditory discrimination task. A preliminary report.
Topics: Adult; Antipsychotic Agents; Arousal; Attention; Cerebral Cortex; Dominance, Cerebral; Dose-Response Relationship, Drug; Evoked Potentials, Auditory; Female; Humans; Male; Methamphetamine; Middle Aged; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Reaction Time; Reference Values; Speech Perception | 1993 |
Dopamine D2 and serotonin S2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomography.
Topics: Adult; Cerebral Cortex; Corpus Striatum; Frontal Lobe; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Radioligand Assay; Receptors, Dopamine D2; Receptors, Serotonin; Spiperone; Substance-Related Disorders; Tomography, Emission-Computed | 1993 |
[Changes of the dopamine uptake sites in the rat striatum induced by repeated methamphetamine administration: a neurochemical approach to a mechanism of relapse in amphetamine psychosis].
Topics: Amphetamine; Animals; Behavior, Animal; Benzamides; Benzazepines; Binding Sites; Corpus Striatum; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Methamphetamine; Psychoses, Substance-Induced; Rats; Recurrence | 1993 |
[Reverse-tolerance phenomenon in methamphetamine-induced behavioral stereotypy and impairment of cliff avoidance reaction after subchronic methamphetamine administration in rats].
Topics: Animals; Avoidance Learning; Central Nervous System Stimulants; Cognition Disorders; Disease Models, Animal; Male; Methamphetamine; Psychoses, Substance-Induced; Rats; Rats, Sprague-Dawley; Stereotyped Behavior | 1995 |
Monoamine neurotransmitter function and spontaneous recurrence of methamphetamine psychosis.
Topics: Adult; Anxiety; Biogenic Monoamines; Female; Humans; Methamphetamine; Psychoses, Substance-Induced; Recurrence | 1996 |
Plasma methionine enkephalin-like immunoreactivity in patients with methamphetamine psychosis.
Topics: Adult; Chromatography, High Pressure Liquid; Enkephalin, Methionine; Humans; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induced; Radioimmunoassay | 1996 |
Methamphetamine psychosis: spontaneous recurrence of paranoid-hallucinatory states and monoamine neurotransmitter function.
Topics: Adult; Central Nervous System Stimulants; Fear; Female; Hallucinations; Humans; Mental Recall; Methamphetamine; Norepinephrine; Paranoid Disorders; Psychoses, Substance-Induced; Recurrence | 1997 |
[Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dopamine; Glutamic Acid; Hydroxyindoleacetic Acid; Male; Methamphetamine; Microdialysis; Nitric Oxide; Nucleus Accumbens; Psychoses, Substance-Induced; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Serotonin | 1997 |
Noradrenergic activity and spontaneous recurrence of methamphetamine psychosis.
Topics: Adult; Arousal; Fear; Female; Humans; Mental Recall; Methamphetamine; Norepinephrine; Psychoses, Substance-Induced; Substance-Related Disorders | 1997 |
Risperidone treatment of methamphetamine psychosis.
Topics: Drug Administration Schedule; Humans; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induced; Risperidone; Substance-Related Disorders | 1997 |
[Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].
Topics: 3,4-Methylenedioxyamphetamine; Designer Drugs; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Psychoses, Substance-Induced; Risk Factors | 1997 |
[A study on methamphetamine psychosis in a psychiatric clinic--comparison of acute and chronic-type cases].
Topics: Acute Disease; Adult; Antipsychotic Agents; Chronic Disease; Female; Humans; Japan; Male; Methamphetamine; Middle Aged; Occupations; Prognosis; Psychiatric Department, Hospital; Psychoses, Substance-Induced; Social Environment | 1998 |
P3a of event-related potential in chronic methamphetamine dependence.
Topics: Acoustic Stimulation; Adult; Attention; Auditory Perception; Brief Psychiatric Rating Scale; Electroencephalography; Evoked Potentials, Auditory; Female; Frontal Lobe; Humans; Male; Methamphetamine; Norepinephrine; Psychoses, Substance-Induced; Reading; Substance-Related Disorders | 1998 |
Chronic psychotic illness from methamphetamine.
Topics: Amphetamine-Related Disorders; Brain; Chronic Disease; Humans; Methamphetamine; Psychoses, Substance-Induced; Regional Blood Flow; Substance-Related Disorders; Tomography, Emission-Computed, Single-Photon | 1999 |
Methamphetamine-associated obsessional symptoms and effective risperidone treatment: a case report.
Topics: Adult; Dopamine Antagonists; Humans; Male; Methamphetamine; Obsessive-Compulsive Disorder; Psychoses, Substance-Induced; Risperidone; Serotonin Antagonists; Substance-Related Disorders | 1999 |
The role of gamma-aminobutyric acid (GABA)-benzodiazepine neurotransmission in an animal model of methamphetamine-induced psychosis.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Clonazepam; Depression, Chemical; Disease Models, Animal; Flumazenil; GABA Modulators; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Rats; Rats, Wistar; Receptors, GABA-A; Synaptic Transmission | 1999 |
Effects of repeated administration of methamphetamine on P3-like potentials in rats.
Topics: Animals; Central Nervous System Stimulants; Cerebral Cortex; Conditioning, Operant; Disease Models, Animal; Drug Administration Schedule; Event-Related Potentials, P300; Male; Methamphetamine; Motor Activity; Psychoses, Substance-Induced; Rats; Rats, Sprague-Dawley; Schizophrenia; Stereotypic Movement Disorder; Time Factors | 1999 |
Effects of repeated high-dose methamphetamine on local cerebral glucose utilization in rats.
Topics: Animals; Antimetabolites; Brain; Central Nervous System Stimulants; Deoxyglucose; Glucose; Male; Methamphetamine; Psychoses, Substance-Induced; Rats | 1999 |
Increased sensitivity to stress and episode recurrence in spontaneous recurrence of methamphetamine psychosis.
Topics: Adult; Biogenic Monoamines; Central Nervous System Stimulants; Female; Humans; Methamphetamine; Psychoses, Substance-Induced; Recurrence; Stress, Physiological | 1999 |
Stress induced spontaneous recurrence of methamphetamine psychosis: the relation between stressful experiences and sensitivity to stress.
Topics: Adult; Analysis of Variance; Biogenic Monoamines; Central Nervous System Stimulants; Chi-Square Distribution; Chromatography, High Pressure Liquid; Female; Humans; Methamphetamine; Prisoners; Psychoses, Substance-Induced; Recurrence; Statistics, Nonparametric; Stress, Psychological; Substance-Related Disorders | 2000 |
Increased sensitivity to stress in spontaneous recurrence of methamphetamine psychosis: noradrenergic hyperactivity with contribution from dopaminergic hyperactivity.
Topics: Adult; Arousal; Brain; Central Nervous System Stimulants; Dopamine; Female; Humans; Life Change Events; Mental Recall; Methamphetamine; Norepinephrine; Prisoners; Psychoses, Substance-Induced; Recurrence; Stress, Psychological | 2000 |
Olanzapine treatment of methamphetamine psychosis.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Central Nervous System Stimulants; Humans; Male; Methamphetamine; Olanzapine; Pirenzepine; Psychoses, Substance-Induced; Risperidone | 2000 |
Exacerbation of psychosis by phenylpropanolamine.
Topics: Adult; Female; Hallucinations; Humans; Methamphetamine; Nasal Decongestants; Paranoid Disorders; Paroxetine; Perphenazine; Phenylpropanolamine; Psychoses, Substance-Induced; Recurrence; Substance-Related Disorders | 2000 |
[Clinical features of recent methamphetamine abusers: comparison between smoking abusers and injection abusers].
Topics: Adolescent; Adult; Antipsychotic Agents; Humans; Japan; Methamphetamine; Middle Aged; Prognosis; Psychoses, Substance-Induced; Social Environment; Social Support; Substance Abuse, Intravenous; Substance-Related Disorders | 2000 |
Susceptibility to subsequent episodes in spontaneous recurrence of methamphetamine psychosis.
Topics: Analysis of Variance; Anxiety; Biogenic Monoamines; Case-Control Studies; Central Nervous System Stimulants; Disease Susceptibility; Female; Humans; Methamphetamine; Psychoses, Substance-Induced; Secondary Prevention; Stress, Physiological | 2000 |
Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.
Topics: Adult; Behavior, Addictive; Brain Chemistry; Brief Psychiatric Rating Scale; Carbon Radioisotopes; Carrier Proteins; Caudate Nucleus; Cerebellar Cortex; Cocaine; Dopamine Plasma Membrane Transport Proteins; Humans; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Nerve Tissue Proteins; Nucleus Accumbens; Prefrontal Cortex; Psychoses, Substance-Induced; Putamen; Substance-Related Disorders; Tomography, Emission-Computed | 2001 |
Susceptibility to subsequent episodes of spontaneous recurrence of methamphetamine psychosis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Arousal; Dopamine; Female; Humans; Life Change Events; Methamphetamine; Norepinephrine; Prisoners; Psychoses, Substance-Induced; Recurrence; Risk Factors | 2001 |
Six months follow-up of patients with methamphetamine psychosis.
Topics: Adult; Female; Follow-Up Studies; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Time Factors | 2001 |
Risk factors for treatment-resistive methamphetamine psychosis.
Topics: Adult; Antipsychotic Agents; Brain; Central Nervous System Stimulants; Drug Resistance; Female; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Risk Factors | 2002 |
[An experimental study of onset and relapse mechanisms of the chronic methamphetamine psychosis (author's transl)].
Topics: Animals; Behavior, Animal; Cats; Electroencephalography; Humans; Methamphetamine; Psychoses, Substance-Induced | 1979 |
Amphetamine abuse.
Topics: Administration, Oral; Amphetamine; Barbiturates; Heroin; Humans; Injections, Intravenous; Legislation, Drug; Methamphetamine; Psychoses, Substance-Induced; Substance-Related Disorders; United States | 1975 |
Thought disorder in amphetamine psychosis: a case report.
Topics: Adult; Cognition Disorders; Delusions; Humans; Limbic System; Male; Methamphetamine; Psychoses, Substance-Induced; Stereotyped Behavior | 1976 |
PET dopamine D2 receptors and susceptibility to methamphetamine psychosis.
Topics: Adult; Brain; Brain Chemistry; Dopamine Agents; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone; Tomography, Emission-Computed | 1992 |
Crystal methamphetamine abuse: a concern to oral and maxillofacial surgeons.
Topics: Administration, Oral; Humans; Intraoperative Complications; Methamphetamine; Psychoses, Substance-Induced; Receptors, Dopamine; Substance-Related Disorders; Surgery, Oral | 1992 |
Chronic methamphetamine intoxication model of schizophrenia in animals.
Topics: Animals; Behavior, Animal; Cats; Disease Models, Animal; Female; Guinea Pigs; Male; Methamphetamine; Mice; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology | 1992 |
A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis.
Topics: Brain; Dopamine; Hallucinations; Humans; Incidence; Japan; Methamphetamine; Paranoid Disorders; Psychoses, Substance-Induced; Recurrence; Substance-Related Disorders; Time Factors | 1992 |
P300 in methamphetamine psychosis.
Topics: Adult; Arousal; Cerebral Cortex; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Male; Methamphetamine; Middle Aged; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Reaction Time; Schizophrenic Psychology | 1991 |
Chronic schizophrenia-like states in methamphetamine psychosis.
Topics: Adult; Arousal; Diagnosis, Differential; Female; Humans; Male; Methamphetamine; Middle Aged; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Substance Abuse, Intravenous; Substance-Related Disorders; Thinking | 1990 |
[Relationship between years of methamphetamine use and symptoms of methamphetamine psychosis].
Topics: Adolescent; Adult; Age Factors; Aged; Child; Emotions; Female; Humans; Male; Methamphetamine; Middle Aged; Personality; Psychoses, Substance-Induced; Sex Factors; Social Environment; Substance-Related Disorders; Time Factors | 1990 |
Eye movements in acute, chronic, and remitted schizophrenics.
Topics: Acute Disease; Adult; Attention; Chronic Disease; Discrimination Learning; Dominance, Cerebral; Epilepsy, Temporal Lobe; Eye Movements; Female; Fixation, Ocular; Humans; Male; Mental Recall; Methamphetamine; Pattern Recognition, Visual; Psychiatric Status Rating Scales; Psychomotor Performance; Psychoses, Substance-Induced; Pursuit, Smooth; Reaction Time; Schizophrenia; Schizophrenic Psychology | 1990 |
Methamphetamine psychosis in Japan: a survey.
Topics: Adult; Cross-Sectional Studies; Female; Humans; Incidence; Japan; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induced; Substance-Related Disorders | 1989 |
Hazards of smokable methamphetamine.
Topics: Humans; Methamphetamine; Psychoses, Substance-Induced; Substance-Related Disorders | 1989 |
[The clinical course of chronic methamphetamine psychoses].
Topics: Adult; Chronic Disease; Delusions; Hallucinations; Humans; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induced; Substance-Related Disorders | 1989 |
[Effects of selective D-1 and D-2 dopamine antagonists on methamphetamine-induced behavioral sensitization].
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzamides; Benzazepines; Methamphetamine; Psychoses, Substance-Induced; Rats; Rats, Inbred Strains | 1988 |
[Changes in behavior and central monoaminergic systems in the rat after repeated methamphetamine pretreatment: presynaptic regulatory mechanism].
Topics: Animals; Behavior, Animal; Biogenic Monoamines; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Male; Methamphetamine; Psychoses, Substance-Induced; Rats; Rats, Inbred Strains | 1988 |
[Study on experimental models of methamphetamine-induced mental disorders--relationship between rat brain dopamine and changes in behavior].
Topics: Animals; Behavior, Animal; Brain; Dopamine; Methamphetamine; Psychoses, Substance-Induced; Rats; Receptors, Dopamine | 1988 |
Synergism between methamphetamine and alcohol in a case of methamphetamine psychosis.
Topics: Adult; Alcoholism; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Substance-Related Disorders | 1986 |
Acute exacerbation of methamphetamine psychosis and lasting dopaminergic supersensitivity--a clinical survey.
Topics: Adult; Brain; Female; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Receptors, Dopamine | 1986 |
Reverse tolerance to the ambulation-increasing effect of methamphetamine in mice as an animal model of amphetamine-psychosis.
Topics: Animals; Disease Models, Animal; Drug Tolerance; Humans; Methamphetamine; Mice; Mice, Inbred Strains; Motor Activity; Psychoses, Substance-Induced; Rats | 1986 |
Psychotic manifestations in amphetamine abuse--experimental study on the mechanism of psychotic recurrence.
Topics: Animals; Conditioning, Operant; Dextroamphetamine; Disease Models, Animal; Male; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Psychoses, Substance-Induced; Rats; Rats, Inbred Strains; Recurrence | 1986 |
Visual perception process in amphetamine psychosis and schizophrenia.
Topics: Chronic Disease; Eye Movements; Humans; Methamphetamine; Psychoses, Substance-Induced; Schizophrenic Psychology; Visual Perception | 1986 |
Electron microscopic studies concerning the structural mechanism of the development of mental disturbance in experimental chronic methamphetamine poisoning.
Topics: Animals; Brain; Cerebral Cortex; Cytoplasm; Humans; Limbic System; Male; Methamphetamine; Microscopy, Electron; Neural Conduction; Neurons; Psychoses, Substance-Induced; Rats; Synapses; Synaptic Transmission | 1969 |
The experimental reproduction of amphetamine psychosis.
Topics: Abreaction; Adolescent; Adult; Blood Pressure; Female; Hallucinations; Humans; Male; Methamphetamine; Psychological Tests; Psychoses, Substance-Induced; Substance-Related Disorders; Vision, Ocular | 1973 |
Olfactory forebrain seizures induced by methamphetamine and disulfiram.
Topics: Amphetamine; Animals; Brain; Brain Chemistry; Cats; Disease Models, Animal; Disulfiram; Dopamine; Electroencephalography; Epilepsy, Temporal Lobe; Female; Humans; Limbic System; Methamphetamine; Norepinephrine; Olfactory Bulb; Pattern Recognition, Automated; Psychoses, Substance-Induced; Seizures; Substantia Nigra | 1973 |
Behavior and EEG analysis of chronic amphetamine effect.
Topics: Amphetamine; Amygdala; Animals; Arousal; Behavior, Animal; Cats; Disease Models, Animal; Electroencephalography; Hallucinations; Humans; Limbic System; Methamphetamine; Motor Activity; Olfactory Bulb; Psychoses, Substance-Induced; Seizures | 1974 |
Stereotyped activities produced by amphetamine in several animal species and man.
Topics: Animals; Behavior, Animal; Cats; Chickens; Columbidae; Dextroamphetamine; Female; Guinea Pigs; Haplorhini; Hominidae; Humans; Male; Methamphetamine; Mice; Motor Activity; Phenmetrazine; Psychoses, Substance-Induced; Species Specificity | 1967 |
Effect of chronic methamphetamine intoxication in Rhesus monkeys.
Topics: Animals; Behavior, Animal; Exploratory Behavior; Female; Haplorhini; Humans; Hyperkinesis; Macaca; Male; Methamphetamine; Motor Activity; Psychoses, Substance-Induced | 1971 |
Amphetamine and other non-opioid drug users attending a special drug dependence clinic.
Topics: Adolescent; Adult; Age Factors; Amphetamine; Barbiturates; Chloroform; Depression; Drug and Narcotic Control; Female; Forensic Medicine; Humans; Injections, Intravenous; London; Male; Methamphetamine; Psychoses, Substance-Induced; Schools; Substance-Related Disorders; Suicide | 1972 |
Marihuana. Effects on deep and surface electroencephalograms of man.
Topics: Adult; Behavior; Brain; Cannabis; Cerebral Cortex; Electrodes, Implanted; Electroencephalography; Ethanol; Euphoria; Humans; Limbic System; Male; Methamphetamine; Nicotiana; Plants, Toxic; Psychoses, Substance-Induced; Smoking; Substance-Related Disorders | 1972 |
Behavioral analysis of chronic amphetamine intoxication.
Topics: Animals; Attitude; Behavior, Animal; Cats; Disease Models, Animal; Electroencephalography; Humans; Methamphetamine; Motor Activity; Movement Disorders; Paranoid Disorders; Posture; Psychoses, Substance-Induced | 1972 |
Amphetamines in human urine: rapid estimation by gas-liquid chromatography.
Topics: Acetates; Amphetamine; Anhydrides; Chloroform; Chromatography, Gas; Humans; Hydrogen-Ion Concentration; Mephentermine; Methamphetamine; Methods; Phenethylamines; Psychoses, Substance-Induced | 1970 |
An analysis of 310 cases of acute high-dose methamphetamine toxicity in Haight-Ashbury.
Topics: Anxiety; Drug Tolerance; Fatigue; Gastrointestinal Diseases; Hepatitis; Humans; Injections, Intravenous; Methamphetamine; Psychoses, Substance-Induced; Substance Withdrawal Syndrome; Substance-Related Disorders | 1970 |
[Prognostic and criminological studies on the mental disorder caused by the chronic methamphetamine intoxication].
Topics: Adolescent; Adult; Child; Criminal Psychology; Humans; Male; Methamphetamine; Middle Aged; Prognosis; Psychoses, Substance-Induced; Substance-Related Disorders | 1967 |
[A study on the experimental production in the brain of histopathological changes resembling schizophrenia by chronic methamphetamine administration].
Topics: Animals; Brain; Guinea Pigs; Humans; Male; Methamphetamine; Microscopy, Electron; Psychoses, Substance-Induced; Schizophrenia | 1967 |
The use and abuse of LSD in Haight-Ashbury (observations by the Haight-Ashbury Medical Clinic).
Topics: Behavior; California; Chromosome Aberrations; Chromosome Disorders; Drug Contamination; Humans; Lysergic Acid Diethylamide; Methamphetamine; Psychoses, Substance-Induced; Substance-Related Disorders | 1968 |
[An electron-microscopic study on the mechanism of mental disturbances in experimentally induced chronic methamphetamine administration].
Topics: Animals; Brain; Guinea Pigs; Humans; Male; Methamphetamine; Microscopy, Electron; Psychoses, Substance-Induced | 1969 |
Behavioral aberrations in methamphetamine-intoxicated animals and chemical correlates in the brain.
Topics: Animals; Behavior, Animal; Brain Chemistry; Cats; Guinea Pigs; Humans; Methamphetamine; Mice; Psychoses, Substance-Induced; Rats | 1966 |